The	O
molecular	O
and	O
phenotypic	O
profile	O
of	O
primary	O
central	O
nervous	O
system	O
lymphoma	O
identifies	O
distinct	O
categories	O
of	O
the	O
disease	O
and	O
is	O
consistent	O
with	O
histogenetic	O
derivation	O
from	O
germinal	B-cell_type
center-related	I-cell_type
B	I-cell_type
cells	I-cell_type
.	O

Primary	O
central	O
nervous	O
system	O
lymphoma	O
(	O
PCNSL	O
)	O
is	O
a	O
major	O
cause	O
of	O
morbidity	O
and	O
mortality	O
among	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
-infected	O
individuals	O
.	O

The	O
precise	O
histogenetic	O
derivation	O
and	O
the	O
molecular	O
pathogenesis	O
of	O
PCNSL	O
is	O
poorly	O
understood	O
.	O

In	O
an	O
attempt	O
to	O
clarify	O
the	O
histogenesis	O
and	O
pathogenesis	O
of	O
these	O
lymphomas	O
,	O
49	O
PCNSL	O
(	O
26	O
acquired	O
immunodeficiency	O
syndrome	O
[	O
AIDS	O
]	O
-related	O
and	O
23	O
AIDS-unrelated	O
)	O
were	O
analyzed	O
for	O
multiple	O
biologic	O
markers	O
,	O
which	O
are	O
known	O
to	O
bear	O
histogenetic	O
and	O
pathogenetic	O
significance	O
for	O
mature	O
B-cell	O
neoplasms	O
.	O

PCNSL	O
associated	O
frequently	O
(	O
50.0	O
%	O
)	O
with	O
mutations	O
of	O
BCL-6	B-DNA
5	I-DNA
'	I-DNA
noncoding	I-DNA
regions	I-DNA
,	O
which	O
are	O
regarded	O
as	O
a	O
marker	O
of	O
B-cell	O
transition	O
through	O
the	O
germinal	O
center	O
(	O
GC	O
)	O
.	O

Expression	O
of	O
BCL-6	B-protein
protein	I-protein
,	O
which	O
is	O
restricted	O
to	O
GC	B-cell_type
B	I-cell_type
cells	I-cell_type
throughout	O
physiologic	O
B-cell	O
maturation	O
,	O
was	O
detected	O
in	O
100	O
%	O
AIDS-unrelated	O
PCNSL	O
and	O
in	O
56.2	O
%	O
AIDS-related	O
cases	O
.	O

Notably	O
,	O
among	O
AIDS-related	O
PCNSL	O
,	O
expression	O
of	O
BCL-6	B-protein
was	O
mutually	O
exclusive	O
with	O
expression	O
of	O
Epstein-Barr	B-protein
virus	I-protein
(	I-protein
EBV	I-protein
)	I-protein
-encoded	I-protein
latent	I-protein
membrane	I-protein
protein	I-protein
(	I-protein
LMP	I-protein
)	I-protein
-1	I-protein
and	O
,	O
with	O
few	O
exceptions	O
,	O
also	O
of	O
BCL-2	B-protein
.	O

All	O
but	O
one	O
PCNSL	O
expressed	O
hMSH2	O
,	O
which	O
among	O
mature	B-cell_type
B	I-cell_type
cells	I-cell_type
selectively	O
stains	O
GC	B-cell_type
B	I-cell_type
cells	I-cell_type
.	O

These	O
data	O
suggest	O
that	O
PCNSL	O
may	O
be	O
frequently	O
related	O
to	O
GC	B-cell_type
B	I-cell_type
cells	I-cell_type
and	O
may	O
be	O
segregated	O
into	O
two	O
major	O
biologic	O
categories	O
based	O
on	O
the	O
expression	O
pattern	O
of	O
BCL-6	B-protein
,	O
LMP-1	B-protein
,	O
and	O
BCL-2	B-protein
.	O

BCL-6	B-protein
(	O
+	O
)	O
/	O
LMP-1	B-protein
(	O
-	O
)	O
/	O
BCL-2	B-protein
(	O
-	O
)	O
PCNSL	O
occur	O
both	O
in	O
the	O
presence	O
and	O
in	O
the	O
absence	O
of	O
HIV	O
infection	O
and	O
consistently	O
display	O
a	O
large	O
noncleaved	O
cell	O
morphology	O
.	O

Conversely	O
,	O
BCL-6	B-protein
(	O
-	O
)	O
/	O
LMP-1	B-protein
(	O
+	O
)	O
/	O
BCL-2	B-protein
(	O
+	O
)	O
PCNSL	O
are	O
restricted	O
to	O
HIV-infected	O
hosts	O
and	O
are	O
represented	O
by	O
lymphomas	O
with	O
immunoblastic	O
features	O
.	O

These	O
data	O
are	O
relevant	O
for	O
the	O
pathogenesis	O
and	O
histogenesis	O
of	O
PCNSL	O
and	O
may	O
be	O
helpful	O
to	O
segregate	O
distinct	O
biologic	O
and	O
prognostic	O
categories	O
of	O
these	O
lymphomas	O
.	O

Copyright	O
1998	O
by	O
The	O
American	O
Society	O
of	O
Hematology	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

The	NULL
Molecular	NULL
and	NULL
Phenotypic	NULL
Profile	NULL
of	NULL
Primary	NULL
Central	NULL
Nervous	NULL
System	NULL
Lymphoma	NULL
Identifies	NULL
Distinct	NULL
Categories	NULL
of	NULL
the	NULL
Disease	NULL
and	NULL
Is	NULL
Consistent	NULL
With	NULL
Histogenetic	NULL
Derivation	NULL
From	NULL
Germinal	NULL
Center-Related	NULL
B	NULL
Cells	NULL
By	NULL
Luigi	NULL
Maria	NULL
Larocca	NULL
,	NULL
Daniela	NULL
Capello	NULL
,	NULL
Alessandro	NULL
Rinelli	NULL
,	NULL
Simonetta	NULL
Nori	NULL
,	NULL
Andrea	NULL
Antinori	NULL
,	NULL
Annunziata	NULL
Gloghini	NULL
,	NULL
Antonella	NULL
Cingolani	NULL
,	NULL
Anna	NULL
Migliazza	NULL
,	NULL
Giuseppe	NULL
Saglio	NULL
,	NULL
Sophie	NULL
Cammilleri-Broet	NULL
,	NULL
Martine	NULL
Raphael	NULL
,	NULL
Antonino	NULL
Carbone	NULL
,	NULL
and	NULL
Gianluca	NULL
Gaidano	NULL
Primary	NULL
central	NULL
nervous	NULL
system	NULL
lymphoma	NULL
(	NULL
PCNSL	NULL
)	NULL
is	NULL
a	NULL
major	NULL
cause	NULL
of	NULL
morbidity	NULL
and	NULL
mortality	NULL
among	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
-infected	NULL
individuals	NULL
.	NULL

The	NULL
precise	NULL
histogenetic	NULL
derivation	NULL
and	NULL
the	NULL
molecular	NULL
pathogenesis	NULL
of	NULL
PCNSL	NULL
is	NULL
poorly	NULL
understood	NULL
.	NULL

In	NULL
an	NULL
attempt	NULL
to	NULL
clarify	NULL
the	NULL
histogenesis	NULL
and	NULL
pathogenesis	NULL
of	NULL
these	NULL
lymphomas	NULL
,	NULL
49	NULL
PCNSL	NULL
(	NULL
26	NULL
acquired	NULL
immunodeficiency	NULL
syndrome	NULL
[	NULL
AIDS	NULL
]	NULL
-related	NULL
and	NULL
23	NULL
AIDS-unrelated	NULL
)	NULL
were	NULL
analyzed	NULL
for	NULL
multiple	NULL
biologic	NULL
markers	NULL
,	NULL
which	NULL
are	NULL
know	NULL
n	NULL
to	NULL
bear	NULL
histogenetic	NULL
and	NULL
pathogenetic	NULL
significance	NULL
for	NULL
mature	NULL
B-cell	NULL
neoplasms	NULL
.	NULL

PCNSL	NULL
associated	NULL
frequently	NULL
(	NULL
50.0	NULL
%	NULL
)	NULL
with	NULL
mutations	NULL
of	NULL
BCL-6	NULL
5	NULL
'	NULL
noncoding	NULL
regions	NULL
,	NULL
w	NULL
hich	NULL
are	NULL
regarded	NULL
as	NULL
a	NULL
marker	NULL
of	NULL
B-cell	NULL
transition	NULL
through	NULL
the	NULL
germinal	NULL
center	NULL
(	NULL
GC	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
BCL-6	NULL
protein	NULL
,	NULL
which	NULL
is	NULL
restricted	NULL
to	NULL
GC	NULL
B	NULL
cells	NULL
throughout	NULL
physiologic	NULL
B-cell	NULL
maturation	NULL
,	NULL
was	NULL
detected	NULL
in	NULL
100	NULL
%	NULL
AIDS-unrelated	NULL
PCNSL	NULL
and	NULL
in	NULL
56.2	NULL
%	NULL
AIDS-related	NULL
cases	NULL
.	NULL

Notably	NULL
,	NULL
among	NULL
AIDS-related	NULL
PCNSL	NULL
,	NULL
expression	NULL
of	NULL
RIMARY	NULL
CENTRAL	NULL
NERVOUS	NULL
system	NULL
lymphoma	NULL
(	NULL
PCNSL	NULL
)	NULL
is	NULL
a	NULL
major	NULL
cause	NULL
of	NULL
morbidity	NULL
and	NULL
mortality	NULL
among	NULL
individuals	NULL
infected	NULL
by	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
.	NULL

The	NULL
relative	NULL
risk	NULL
of	NULL
PCNSL	NULL
among	NULL
HIV-infected	NULL
hosts	NULL
approximates	NULL
1,000	NULL
when	NULL
compared	NULL
with	NULL
the	NULL
HIV-negative	NULL
population	NULL
.	NULL
``	NULL

''	NULL
Although	NULL
PCNSL	NULL
has	NULL
been	NULL
formally	NULL
considered	NULL
rare	NULL
in	NULL
HIV~	NULL
hosts	NULL
,	NULL
recent	NULL
epidemiologic	NULL
evidence	NULL
suggests	NULL
that	NULL
the	NULL
incidence	NULL
of	NULL
the	NULL
disease	NULL
in	NULL
apparently	NULL
immunocompetent	NULL
individuals	NULL
has	NULL
been	NULL
increasing	NULL
dramatically	NULL
during	NULL
the	NULL
last	NULL
two	NULL
decades	NULL
.	NULL
``	NULL

Virtually	NULL
all	NULL
acquired	NULL
immunodeficiency	NULL
syndrome	NULL
(	NULL
AIDS	NULL
)	NULL
-related	NULL
and	NULL
the	NULL
majority	NULL
of	NULL
AIDS-unrelated	NULL
PCNSL	NULL
derive	NULL
from	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
in	NULL
all	NULL
cases	NULL
present	NULL
as	NULL
clinically	NULL
aggressive	NULL
tumors	NULL
.	NULL

'**	NULL
Histologically	NULL
,	NULL
the	NULL
overwhelming	NULL
majority	NULL
of	NULL
PCNSL	NULL
is	NULL
represented	NULL
by	NULL
diffuse	NULL
large	NULL
B-cell	NULL
lymphomas	NULL
(	NULL
DLCL	NULL
)	NULL
.	NULL

Depending	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
immunoblastic	NULL
plasmocytoid	NULL
features	NULL
,	NULL
PCNSL	NULL
may	NULL
be	NULL
further	NULL
distinguished	NULL
into	NULL
large	NULL
noncleaved	NULL
cell	NULL
lymphoma	NULL
(	NULL
LNCCL	NULL
)	NULL
and	NULL
immunoblastic	NULL
plasmocytoid	NULL
lymphoma	NULL
(	NULL
IBPL	NULL
)	NULL
.8*	NULL
The	NULL
histogenetic	NULL
derivation	NULL
of	NULL
PCNSL	NULL
is	NULL
poorly	NULL
understood	NULL
.	NULL

Because	NULL
the	NULL
central	NULL
nervous	NULL
system	NULL
(	NULL
CNS	NULL
)	NULL
lacks	NULL
lymph	NULL
nodes	NULL
and	NULL
lymphatics	NULL
,	NULL
it	NULL
has	NULL
been	NULL
hypothesized	NULL
that	NULL
PCNSL	NULL
may	NULL
originate	NULL
from	NULL
B	NULL
cells	NULL
derived	NULL
from	NULL
systemic	NULL
lymphoid	NULL
tissues	NULL
and	NULL
normally	NULL
trafficking	NULL
in	NULL
and	NULL
out	NULL
of	NULL
the	NULL
CNS	NULL
.	NULL

The	NULL
molecular	NULL
pathogenesis	NULL
of	NULL
PCNSL	NULL
is	NULL
also	NULL
uncertain	NULL
,	NULL
and	NULL
existing	NULL
evidence	NULL
is	NULL
mainly	NULL
restricted	NULL
to	NULL
the	NULL
role	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
.	NULL

Infection	NULL
by	NULL
EBV	NULL
occurs	NULL
in	NULL
all	NULL
AIDS-related	NULL
PCNSL	NULL
,	NULL
whereas	NULL
it	NULL
is	NULL
negative	NULL
in	NULL
AIDS-unrelated	NULL
cases	NULL
.	NULL
``	NULL

''	NULL
AIDS-related	NULL
PCNSL	NULL
frequently	NULL
express	NULL
the	NULL
EB	NULL
V-encoded	NULL
latent	NULL
membrane	NULL
protein-1	NULL
(	NULL
LMP-1	NULL
)	NULL
antigen	NULL
,	NULL
which	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
upregulates	NULL
the	NULL
expression	NULL
of	NULL
BCL-2	NULL
.	NULL

!	NULL

5	NULL
Because	NULL
PCNSL	NULL
are	NULL
consistently	NULL
monoclonal	NULL
,	NULL
however	NULL
,	NULL
it	NULL
is	NULL
conceivable	NULL
that	NULL
EBV	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
tumor	NULL
development	NULL
.	NULL

BCL-6	NULL
is	NULL
a	NULL
proto-oncogene	NULL
coding	NULL
for	NULL
a	NULL
zinc	NULL
finger	NULL
transcrip-tional	NULL
repressor	NULL
which	NULL
,	NULL
in	NULL
the	NULL
B-cell	NULL
lineage	NULL
,	NULL
is	NULL
expressed	NULL
selectively	NULL
by	NULL
germinal	NULL
center	NULL
(	NULL
GC	NULL
)	NULL
B	NULL
cells	NULL
.	NULL
``	NULL

Notably	NULL
,	NULL
animal	NULL
models	NULL
have	NULL
demonstrated	NULL
that	NULL
expression	NULL
of	NULL
BCL-6	NULL
is	NULL
an	NULL
absolute	NULL
requirement	NULL
for	NULL
physiologic	NULL
GC	NULL
formation	NULL
and	NULL
Blood	NULL
,	NULL
Vol	NULL
92	NULL
,	NULL
No	NULL
3	NULL
(	NULL
August	NULL
1	NULL
)	NULL
,	NULL
1998	NULL
:	NULL
pp	NULL
1011-1019	NULL
BCL-6	NULL
was	NULL
mutually	NULL
exclusive	NULL
with	NULL
expression	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
-encoded	NULL
latent	NULL
membrane	NULL
protein	NULL
(	NULL
LMP	NULL
)	NULL
-1	NULL
and	NULL
,	NULL
with	NULL
few	NULL
exceptions	NULL
,	NULL
also	NULL
of	NULL
BCL-2	NULL
.	NULL

All	NULL
but	NULL
one	NULL
PCNSL	NULL
expressed	NULL
hMSH2	NULL
,	NULL
which	NULL
among	NULL
mature	NULL
B	NULL
cells	NULL
selectively	NULL
stains	NULL
GC	NULL
B	NULL
cells	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
PCNSL	NULL
may	NULL
be	NULL
frequently	NULL
related	NULL
to	NULL
GC	NULL
B	NULL
cells	NULL
and	NULL
may	NULL
be	NULL
segregated	NULL
into	NULL
two	NULL
major	NULL
biologic	NULL
categories	NULL
based	NULL
on	NULL
the	NULL
expression	NULL
pattern	NULL
of	NULL
BCL-6	NULL
,	NULL
LMP-1	NULL
,	NULL
and	NULL
BCL-2	NULL
.	NULL

BCL-6+/LMP-1~/	NULL
BCL-2~	NULL
PCNSL	NULL
occur	NULL
both	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
HIV	NULL
infection	NULL
and	NULL
consistently	NULL
display	NULL
a	NULL
large	NULL
noncleaved	NULL
cell	NULL
morphology	NULL
.	NULL

Conversely	NULL
,	NULL
BCL-6~/LMP-1+/	NULL
BCL-2+	NULL
PCNSL	NULL
are	NULL
restricted	NULL
to	NULL
HIV-infected	NULL
hosts	NULL
and	NULL
are	NULL
represented	NULL
by	NULL
lymphomas	NULL
with	NULL
immunoblastic	NULL
features	NULL
.	NULL

These	NULL
data	NULL
are	NULL
relevant	NULL
for	NULL
the	NULL
pathogenesis	NULL
and	NULL
histogenesis	NULL
of	NULL
PCNSL	NULL
and	NULL
may	NULL
be	NULL
helpful	NULL
to	NULL
segregate	NULL
distinct	NULL
biologic	NULL
and	NULL
prognostic	NULL
categories	NULL
of	NULL
these	NULL
lymphomas	NULL
.	NULL

©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

function	NULL
.	NULL
``	NULL

''	NULL
Genetic	NULL
alterations	NULL
of	NULL
BCL-6	NULL
occur	NULL
frequently	NULL
among	NULL
systemic	NULL
B-cell	NULL
non-Hodgkin	NULL
's	NULL
lymphomas	NULL
(	NULL
NHL	NULL
)	NULL
and	NULL
are	NULL
represented	NULL
by	NULL
gross	NULL
rearrangements	NULL
and	NULL
mutations	NULL
of	NULL
the	NULL
5	NULL
'	NULL
noncoding	NULL
regions	NULL
of	NULL
the	NULL
gene	NULL
.	NULL
'	NULL

''	NULL
``	NULL
>	NULL
**	NULL
Among	NULL
systemic	NULL
B-NHL	NULL
,	NULL
rearrangements	NULL
of	NULL
BCL-6	NULL
cluster	NULL
with	NULL
B-cell	NULL
DLCL	NULL
.	NULL

*	NULL
Conversely	NULL
,	NULL
mutations	NULL
of	NULL
the	NULL
BCL-6	NULL
5	NULL
'	NULL
noncoding	NULL
regions	NULL
occur	NULL
frequently	NULL
and	NULL
selectively	NULL
in	NULL
B-cell	NULL
NHL	NULL
arising	NULL
from	NULL
GC	NULL
or	NULL
post-GC	NULL
B	NULL
cells	NULL
.	NULL

*	NULL
``	NULL
*	NULL
``	NULL
``	NULL
On	NULL
this	NULL
basis	NULL
,	NULL
BCL-6	NULL
mutations	NULL
are	NULL
regarded	NULL
as	NULL
a	NULL
marker	NULL
of	NULL
B-cell	NULL
transition	NULL
through	NULL
the	NULL
GC	NULL
.	NULL

From	NULL
the	NULL
Institute	NULL
of	NULL
Pathology	NULL
,	NULL
Catholic	NULL
University	NULL
of	NULL
the	NULL
Sacred	NULL
Heart	NULL
,	NULL
Rome	NULL
;	NULL
Division	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Department	NULL
of	NULL
Medical	NULL
Sciences	NULL
,	NULL
University	NULL
of	NULL
Torino	NULL
at	NULL
Novara	NULL
,	NULL
Novara	NULL
;	NULL
Institute	NULL
of	NULL
Infectious	NULL
Diseases	NULL
,	NULL
Catholic	NULL
University	NULL
of	NULL
the	NULL
Sacred	NULL
Heart	NULL
,	NULL
Rome	NULL
;	NULL
Division	NULL
of	NULL
Pathology	NULL
,	NULL
INRCCS-Centro	NULL
di	NULL
Riferimento	NULL
Oncologico	NULL
,	NULL
Aviano	NULL
;	NULL
Department	NULL
of	NULL
Clinical	NULL
and	NULL
Biological	NULL
Sciences	NULL
,	NULL
University	NULL
of	NULL
Torino	NULL
,	NULL
Or-bassano-Torino	NULL
,	NULL
Italy	NULL
;	NULL
Division	NULL
of	NULL
Oncology	NULL
,	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
College	NULL
of	NULL
Physicians	NULL
&	NULL
Surgeons	NULL
,	NULL
Columbia	NULL
University	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
;	NULL
Laboratoire	NULL
de	NULL
Neuropathologie	NULL
,	NULL
Pitié	NULL
Salpétriére	NULL
,	NULL
Paris	NULL
;	NULL
Service	NULL
d'Hematologie	NULL
Biologique	NULL
,	NULL
Hopital	NULL
Avicenne	NULL
,	NULL
Bobigny	NULL
,	NULL
Université	NULL
de	NULL
Paris	NULL
XI	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
.	NULL

Submitted	NULL
December	NULL
29	NULL
,	NULL
1997	NULL
;	NULL
accepted	NULL
March	NULL
26	NULL
,	NULL
1998	NULL
.	NULL

Supported	NULL
by	NULL
grants	NULL
from	NULL
Programma	NULL
Nazionale	NULL
di	NULL
Ricerca	NULL
sull	NULL
AIDS-1997	NULL
,	NULL
Istituto	NULL
Superiore	NULL
di	NULL
Sanita	NULL
,	NULL
Rome	NULL
,	NULL
Italy	NULL
;	NULL
the	NULL
Associazione	NULL
Italiana	NULL
per	NULL
la	NULL
Ricerca	NULL
sul	NULL
Cancro	NULL
,	NULL
Milan	NULL
,	NULL
Italy	NULL
;	NULL
and	NULL
the	NULL
``	NULL
Fondazione	NULL
Piera	NULL
,	NULL
Pietro	NULL
e	NULL
Giovanni	NULL
Ferrero	NULL
,	NULL
``	NULL
Alba	NULL
,	NULL
Italy	NULL
.	NULL

D.C.	NULL
is	NULL
being	NULL
supported	NULL
by	NULL
a	NULL
fellowship	NULL
from	NULL
``	NULL
Fondazione	NULL
Piera	NULL
,	NULL
Pietro	NULL
e	NULL
Giovanni	NULL
Ferrero	NULL
,	NULL
``	NULL
Alba	NULL
,	NULL
Italy	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Luigi	NULL
Maria	NULL
Larocca	NULL
,	NULL
MD	NULL
,	NULL
Divison	NULL
of	NULL
Pathology	NULL
,	NULL
Universita	NULL
Cattolica	NULL
del	NULL
Sacro	NULL
Cuore	NULL
,	NULL
Largo	NULL
F.	NULL
Vito	NULL
,	NULL
1	NULL
,	NULL
Rome	NULL
1-00168	NULL
,	NULL
Italy	NULL
;	NULL
e-mail	NULL
:	NULL
ibiap	NULL
@	NULL
rm.unicatt.it	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/98/9203-0004	NULL
$	NULL
3.00/0	NULL
1011	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1012	NULL
In	NULL
an	NULL
attempt	NULL
to	NULL
clarify	NULL
the	NULL
histogenesis	NULL
and	NULL
pathogenesis	NULL
of	NULL
PCNSL	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
the	NULL
genetic	NULL
status	NULL
and	NULL
expression	NULL
pattern	NULL
of	NULL
BCL-6	NULL
in	NULL
AIDS-related	NULL
and	NULL
AIDS-unrelated	NULL
PCNSL	NULL
.	NULL

Results	NULL
were	NULL
compared	NULL
with	NULL
morphology	NULL
,	NULL
genetic	NULL
profile	NULL
of	NULL
other	NULL
cancer-related	NULL
genes	NULL
,	NULL
and	NULL
expression	NULL
status	NULL
of	NULL
several	NULL
immunophenotypic	NULL
markers	NULL
.	NULL

We	NULL
report	NULL
that	NULL
the	NULL
molecular	NULL
and	NULL
phenotypic	NULL
profile	NULL
of	NULL
PECNSL	NULL
is	NULL
consistent	NULL
with	NULL
an	NULL
origin	NULL
from	NULL
GC	NULL
B	NULL
cells	NULL
in	NULL
most	NULL
cases	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
expression	NULL
pattern	NULL
of	NULL
BCL-6	NULL
,	NULL
LMP-1	NULL
,	NULL
and	NULL
BCL-2	NULL
segregates	NULL
two	NULL
major	NULL
biologic	NULL
categories	NULL
of	NULL
PCNSL	NULL
.	NULL

BCL-6+*+/LMP-1~/BCL-2~	NULL
PCNSL	NULL
consistently	NULL
display	NULL
a	NULL
large	NULL
noncleaved	NULL
cell	NULL
morphology	NULL
and	NULL
occur	NULL
both	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
HIV	NULL
infection	NULL
.	NULL

Conversely	NULL
,	NULL
BCL-6-/LMP-1*/BCL-2+*	NULL
PCNSL	NULL
are	NULL
represented	NULL
by	NULL
lymphomas	NULL
with	NULL
immunoblastic	NULL
features	NULL
and	NULL
are	NULL
mainly	NULL
restricted	NULL
to	NULL
HIV-infected	NULL
hosts	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Tumor	NULL
samples	NULL
.	NULL

|	NULL
This	NULL
study	NULL
was	NULL
based	NULL
on	NULL
tissue	NULL
samples	NULL
of	NULL
a	NULL
total	NULL
of	NULL
49	NULL
cases	NULL
of	NULL
PCNSL	NULL
,	NULL
including	NULL
26	NULL
AIDS-related	NULL
and	NULL
23	NULL
AIDS-unrelated	NULL
cases	NULL
.	NULL

Thirty	NULL
cases	NULL
(	NULL
16	NULL
AIDS-related	NULL
and	NULL
14	NULL
AIDS-unrelated	NULL
)	NULL
were	NULL
derived	NULL
from	NULL
a	NULL
retrospective	NULL
series	NULL
observed	NULL
at	NULL
the	NULL
Institute	NULL
of	NULL
Pathology	NULL
,	NULL
Catholic	NULL
University	NULL
of	NULL
the	NULL
Sacred	NULL
Heart	NULL
,	NULL
Rome	NULL
,	NULL
Italy	NULL
.	NULL

Nine	NULL
cases	NULL
(	NULL
six	NULL
AIDS-related	NULL
and	NULL
three	NULL
AIDS-unrelated	NULL
)	NULL
had	NULL
been	NULL
referred	NULL
to	NULL
the	NULL
Neuropathological	NULL
Laboratory	NULL
(	NULL
Pitié	NULL
Salpétri¢re	NULL
,	NULL
Prof	NULL
J.J.	NULL
Hauw	NULL
)	NULL
.	NULL

The	NULL
remaining	NULL
cases	NULL
had	NULL
been	NULL
referred	NULL
to	NULL
multiple	NULL
different	NULL
institutions	NULL
in	NULL
Europe	NULL
.	NULL

In	NULL
all	NULL
instances	NULL
,	NULL
the	NULL
specimen	NULL
was	NULL
collected	NULL
at	NULL
diagnosis	NULL
before	NULL
starting	NULL
radio	NULL
and/or	NULL
chemotherapy	NULL
.	NULL

For	NULL
morphologic	NULL
diagnosis	NULL
,	NULL
hematoxylin-eosin	NULL
and	NULL
Giemsa	NULL
staining	NULL
was	NULL
performed	NULL
after	NULL
4	NULL
%	NULL
neutral	NULL
buffered	NULL
formalin	NULL
or	NULL
Bouin	NULL
solution	NULL
fixation	NULL
and	NULL
paraffin	NULL
embedding	NULL
.	NULL

Pathologic	NULL
specimens	NULL
were	NULL
classified	NULL
according	NULL
to	NULL
the	NULL
Working	NULL
formulation	NULL
for	NULL
NHL	NULL
and	NULL
to	NULL
a	NULL
revised	NULL
European-American	NULL
classification	NULL
of	NULL
lymphoid	NULL
neoplasms	NULL
(	NULL
REAL	NULL
classification	NULL
)	NULL
.	NULL
``	NULL

All	NULL
PCNSL	NULL
were	NULL
classified	NULL
as	NULL
DLCL	NULL
according	NULL
to	NULL
the	NULL
REAL	NULL
classification	NULL
.	NULL
``	NULL

''	NULL
As	NULL
previously	NULL
reported	NULL
,	NULL
``	NULL
?	NULL

PCNSL	NULL
cases	NULL
were	NULL
further	NULL
subdivided	NULL
into	NULL
two	NULL
histologic	NULL
subtypes	NULL
,	NULL
ie	NULL
,	NULL
LNCCL	NULL
and	NULL
IBPL	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
the	NULL
definition	NULL
of	NULL
LNCCL	NULL
was	NULL
based	NULL
on	NULL
the	NULL
predominance	NULL
(	NULL
>	NULL
80	NULL
%	NULL
)	NULL
of	NULL
cells	NULL
resembling	NULL
large	NULL
noncleaved	NULL
cells	NULL
.	NULL

The	NULL
definition	NULL
of	NULL
IBPL	NULL
was	NULL
based	NULL
on	NULL
the	NULL
predominance	NULL
(	NULL
>	NULL
80	NULL
%	NULL
)	NULL
of	NULL
cells	NULL
resembling	NULL
large	NULL
cells	NULL
,	NULL
immunoblastic	NULL
plasmocyt-oid	NULL
.	NULL

PCNSL	NULL
cases	NULL
containing	NULL
a	NULL
mixture	NULL
of	NULL
large	NULL
noncleaved	NULL
cells	NULL
and	NULL
large	NULL
cells	NULL
,	NULL
immunoblastic	NULL
plasmocytoid	NULL
were	NULL
classified	NULL
separately	NULL
as	NULL
LNCCL/IBPL	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
the	NULL
cytologic	NULL
definition	NULL
of	NULL
large	NULL
noncleaved	NULL
cell	NULL
and	NULL
large	NULL
cell	NULL
,	NULL
immunoblastic	NULL
plasmocytoid	NULL
was	NULL
based	NULL
on	NULL
previously	NULL
reported	NULL
criteria	NULL
.	NULL
``	NULL

''	NULL
Immunohistochemistry	NULL
.	NULL

-	NULL
For	NULL
immunophenotypic	NULL
studies	NULL
,	NULL
the	NULL
avidin-biotin-peroxidase	NULL
complex	NULL
(	NULL
ABC-px	NULL
)	NULL
method	NULL
was	NULL
performed	NULL
on	NULL
paraffin	NULL
sections	NULL
using	NULL
a	NULL
commercially	NULL
available	NULL
kit	NULL
(	NULL
Dako	NULL
LSAB	NULL
2	NULL
;	NULL
Dakopatts	NULL
,	NULL
Glostrup	NULL
,	NULL
Denmark	NULL
)	NULL
and	NULL
the	NULL
following	NULL
commercially	NULL
available	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
MoAbs	NULL
)	NULL
:	NULL
CD3	NULL
,	NULL
CD20	NULL
,	NULL
CD30	NULL
,	NULL
CD4SRA	NULL
,	NULL
CD45RO	NULL
,	NULL
CD57	NULL
,	NULL
CD68	NULL
,	NULL
CD74	NULL
,	NULL
anti-x	NULL
and	NULL
-A	NULL
immunoglobulin	NULL
(	NULL
Ig	NULL
)	NULL
light	NULL
chains	NULL
.	NULL

Immunostaining	NULL
with	NULL
BCL-2	NULL
MoAb	NULL
(	NULL
clone	NULL
bel2/100/D5	NULL
;	NULL
Ylem	NULL
,	NULL
Avezzano	NULL
,	NULL
Italy	NULL
)	NULL
and	NULL
BCL-6	NULL
MoAb	NULL
(	NULL
clone	NULL
PG-B6	NULL
directed	NULL
against	NULL
the	NULL
amino	NULL
terminal	NULL
portion	NULL
of	NULL
the	NULL
human	NULL
BCL-6	NULL
product	NULL
;	NULL
obtained	NULL
from	NULL
Brunangelo	NULL
Falini	NULL
,	NULL
Institute	NULL
of	NULL
Hematology	NULL
,	NULL
University	NULL
of	NULL
Perugia	NULL
,	NULL
Perugia	NULL
,	NULL
Italy	NULL
)	NULL
*	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
alkaline	NULL
antialkaline	NULL
phospha-tase	NULL
(	NULL
APAAP	NULL
)	NULL
methods	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
``	NULL
and/or	NULL
the	NULL
Dako	NULL
Catalyzed	NULL
Signal	NULL
Amplification	NULL
system	NULL
(	NULL
Dako	NULL
K	NULL
1500	NULL
;	NULL
Dakopatts	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
sections	NULL
were	NULL
cut	NULL
at	NULL
a	NULL
thickness	NULL
of	NULL
4	NULL
um	NULL
,	NULL
mounted	NULL
on	NULL
glass	NULL
slides	NULL
coated	NULL
with	NULL
3	NULL
%	NULL
aminopropyltrithoxysilane	NULL
,	NULL
and	NULL
allowed	NULL
to	NULL
air	NULL
dry	NULL
overnight	NULL
(	NULL
ON	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
(	NULL
RT	NULL
)	NULL
.	NULL

After	NULL
dewaxing	NULL
in	NULL
xylene	NULL
and	NULL
rehydration	NULL
in	NULL
a	NULL
series	NULL
of	NULL
ethanols	NULL
,	NULL
the	NULL
sections	NULL
were	NULL
immersed	NULL
in	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
buffer	NULL
pH	NULL
8.0	NULL
and	NULL
pretreated	NULL
twice	NULL
for	NULL
5	NULL
minutes	NULL
at	NULL
750	NULL
W	NULL
in	NULL
a	NULL
microwave	NULL
oven	NULL
(	NULL
MWO	NULL
)	NULL
(	NULL
MWO	NULL
Philips	NULL
M901	NULL
;	NULL
Philips	NULL
,	NULL
LAROCCA	NULL
ET	NULL
AL	NULL
Eindhoven	NULL
,	NULL
The	NULL
Netherlands	NULL
;	NULL
maximum	NULL
power	NULL
900	NULL
W	NULL
)	NULL
.	NULL

After	NULL
cooling	NULL
down	NULL
at	NULL
RT	NULL
,	NULL
sections	NULL
were	NULL
rinsed	NULL
in	NULL
0.05	NULL
mol/L	NULL
Tris-HCI	NULL
]	NULL
buffer	NULL
at	NULL
pH	NULL
7.6	NULL
and	NULL
incubated	NULL
with	NULL
primary	NULL
antibodies	NULL
ON	NULL
at	NULL
4°C	NULL
.	NULL

Biotinylated	NULL
antimouse	NULL
Ig	NULL
were	NULL
then	NULL
applied	NULL
for	NULL
15	NULL
minutes	NULL
,	NULL
followed	NULL
by	NULL
streptavidin-biotin-horseradish	NULL
peroxidase	NULL
complex	NULL
.	NULL

Sections	NULL
were	NULL
washed	NULL
,	NULL
incubated	NULL
with	NULL
biotinylated	NULL
tyramide	NULL
for	NULL
15	NULL
minutes	NULL
,	NULL
washed	NULL
again	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
streptavidin-horseradish	NULL
peroxidase	NULL
.	NULL

After	NULL
washing	NULL
,	NULL
diaminobenzidine	NULL
(	NULL
DAB	NULL
)	NULL
substrate	NULL
was	NULL
used	NULL
as	NULL
chromogen	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
slides	NULL
were	NULL
counterstained	NULL
with	NULL
hematoxylin	NULL
and	NULL
mounted	NULL
in	NULL
permount	NULL
.	NULL

In	NULL
negative	NULL
controls	NULL
,	NULL
the	NULL
primary	NULL
antibody	NULL
was	NULL
substituted	NULL
with	NULL
nonimmune	NULL
mouse	NULL
serum	NULL
.	NULL

The	NULL
LMP-1	NULL
antigen	NULL
was	NULL
detected	NULL
on	NULL
paraffin	NULL
sections	NULL
using	NULL
the	NULL
APAAP	NULL
method	NULL
and	NULL
a	NULL
pool	NULL
of	NULL
four	NULL
anti-LMP-1	NULL
MoAbs	NULL
(	NULL
CS	NULL
1-4	NULL
;	NULL
Dakopatts	NULL
)	NULL
after	NULL
enzymatic	NULL
digestion	NULL
with	NULL
pronase	NULL
(	NULL
Biomeda	NULL
Co	NULL
,	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
hMSH2	NULL
protein	NULL
was	NULL
detected	NULL
by	NULL
using	NULL
an	NULL
anti-hMSH2	NULL
MoAb	NULL
(	NULL
clone	NULL
FE11	NULL
;	NULL
Oncogene	NULL
Science	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
after	NULL
MWO	NULL
pretreat-ment	NULL
in	NULL
sodium-cytrate	NULL
buffer	NULL
(	NULL
0.01	NULL
mol/L	NULL
sodium	NULL
cytrate	NULL
monohydrate	NULL
at	NULL
pH	NULL
6.0	NULL
)	NULL
.	NULL

An	NULL
ABC-px	NULL
method	NULL
was	NULL
used	NULL
with	NULL
DAB	NULL
as	NULL
the	NULL
chromogen	NULL
.	NULL

In	NULL
negative	NULL
controls	NULL
,	NULL
the	NULL
primary	NULL
antibody	NULL
was	NULL
substituted	NULL
with	NULL
nonimmune	NULL
mouse	NULL
serum	NULL
.	NULL

Nonneoplastic	NULL
lymphoid	NULL
samples	NULL
from	NULL
lymph	NULL
node	NULL
,	NULL
spleen	NULL
,	NULL
tonsil	NULL
,	NULL
and	NULL
appendix	NULL
were	NULL
also	NULL
investigated	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
hMSH2	NULL
protein	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
BCL-6+/LMP-1*/BCL-2*	NULL
,	NULL
or	NULL
hMSH2*	NULL
neoplastic	NULL
cells	NULL
was	NULL
assigned	NULL
to	NULL
one	NULL
of	NULL
the	NULL
following	NULL
categories	NULL
:	NULL
0	NULL
,	NULL
less	NULL
than	NULL
10	NULL
%	NULL
;	NULL
10	NULL
%	NULL
to	NULL
25	NULL
%	NULL
;	NULL
25	NULL
%	NULL
to	NULL
50	NULL
%	NULL
;	NULL
50	NULL
%	NULL
to	NULL
75	NULL
%	NULL
;	NULL
and	NULL
greater	NULL
than	NULL
75	NULL
%	NULL
.	NULL

Two-color	NULL
staining	NULL
.	NULL

Multiple	NULL
immunohistochemical	NULL
staining	NULL
was	NULL
performed	NULL
to	NULL
detect	NULL
LMP-1	NULL
plus	NULL
BCL-6	NULL
protein	NULL
in	NULL
selected	NULL
AIDS-related	NULL
PCNSL	NULL
following	NULL
a	NULL
previously	NULL
reported	NULL
strategy	NULL
.	NULL
``	NULL

''	NULL
In	NULL
situ	NULL
hybridization	NULL
(	NULL
ISH	NULL
)	NULL
.	NULL

ISH	NULL
analysis	NULL
of	NULL
EBV-encoded	NULL
small	NULL
RNAs	NULL
(	NULL
EBERs	NULL
)	NULL
is	NULL
a	NULL
highly	NULL
sensitive	NULL
method	NULL
for	NULL
detecting	NULL
latent	NULL
EBV	NULL
infection	NULL
in	NULL
paraffin-embedded	NULL
tissue	NULL
sections	NULL
,	NULL
including	NULL
autopsy	NULL
mate-rial	NULL
.	NULL

For	NULL
each	NULL
case	NULL
tested	NULL
,	NULL
paired	NULL
paraffin	NULL
sections	NULL
were	NULL
mounted	NULL
on	NULL
silanized	NULL
slides	NULL
and	NULL
EBER	NULL
ISH	NULL
studies	NULL
were	NULL
performed	NULL
by	NULL
using	NULL
a	NULL
cocktail	NULL
of	NULL
fluorescein-isothiocyanate-labeled	NULL
oligonucleotides	NULL
complementary	NULL
to	NULL
the	NULL
two	NULL
nuclear	NULL
EBER	NULL
(	NULL
1/2	NULL
)	NULL
RNAs	NULL
,	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
of	NULL
the	NULL
supplier	NULL
(	NULL
Dakopatts	NULL
)	NULL
.	NULL

In	NULL
selected	NULL
cases	NULL
,	NULL
ISH	NULL
mRNA	NULL
studies	NULL
of	NULL
Ig	NULL
light	NULL
chains	NULL
were	NULL
performed	NULL
on	NULL
paraffin-embedded	NULL
tissue	NULL
sections	NULL
to	NULL
assess	NULL
tumor	NULL
clonality	NULL
as	NULL
previously	NULL
reported	NULL
.	NULL
``	NULL

DNA	NULL
extraction	NULL
.	NULL

For	NULL
cryopreserved	NULL
PCNSL	NULL
samples	NULL
,	NULL
genomic	NULL
DNA	NULL
was	NULL
purified	NULL
by	NULL
cell	NULL
lysis	NULL
followed	NULL
by	NULL
digestion	NULL
with	NULL
proteinase	NULL
K	NULL
,	NULL
``	NULL
salting	NULL
out	NULL
``	NULL
extraction	NULL
,	NULL
and	NULL
precipitation	NULL
by	NULL
ethanol	NULL
.	NULL
``	NULL

''	NULL
For	NULL
PCNSL	NULL
samples	NULL
available	NULL
only	NULL
as	NULL
paraffin-embedded	NULL
blocks	NULL
,	NULL
DNA	NULL
extraction	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
reported	NULL
.	NULL

``	NULL
©	NULL
Oligonucleotides	NULL
.	NULL

_	NULL
All	NULL
of	NULL
the	NULL
oligonucleotides	NULL
used	NULL
in	NULL
this	NULL
study	NULL
were	NULL
synthesized	NULL
by	NULL
the	NULL
solid	NULL
phase	NULL
triester	NULL
method	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
BCL-6	NULL
exon	NULL
1-intron	NULL
1	NULL
boundary	NULL
region	NULL
(	NULL
fragments	NULL
E1.10	NULL
,	NULL
E1.11	NULL
,	NULL
and	NULL
E1.12	NULL
)	NULL
was	NULL
as	NULL
follows	NULL
:	NULL
E1.21B	NULL
,	NULL
5'-CTCTTGCCAAAT-GCTTTG-3	NULL
'	NULL
,	NULL
and	NULL
£1.24	NULL
,	NULL
5-TAATTCCCCTCCTITTCCTC-3	NULL
'	NULL
(	NULL
for	NULL
fragment	NULL
E1.10	NULL
)	NULL
;	NULL
£1.23	NULL
,	NULL
5'-AGGAAGGAGGGGAATTAG-3	NULL
'	NULL
,	NULL
and	NULL
IP1.6	NULL
,	NULL
5-AAG-CAGTITTGCAAGCGAG-3	NULL
'	NULL
(	NULL
for	NULL
fragment	NULL
E1.11	NULL
)	NULL
;	NULL
IP1.7	NULL
,	NULL
GCAAACTGC-3	NULL
'	NULL
,	NULL
and	NULL
E1.26	NULL
,	NULL
5-CACGATACTTCATCTCATC-3	NULL
'	NULL
(	NULL
for	NULL
fragment	NULL
E1.12	NULL
)	NULL
.	NULL

>	NULL
The	NULL
oligonucleotides	NULL
used	NULL
as	NULL
primers	NULL
for	NULL
the	NULL
mutational	NULL
analysis	NULL
of	NULL
c-MYC	NULL
first	NULL
exon-first	NULL
intron	NULL
boundary	NULL
region	NULL
have	NULL
been	NULL
reported	NULL
previously	NULL
.	NULL
``	NULL

''	NULL
The	NULL
oligonucleotides	NULL
used	NULL
as	NULL
primers	NULL
for	NULL
the	NULL
analysis	NULL
of	NULL
EBV	NULL
and	NULL
human	NULL
herpesvirus	NULL
type	NULL
8	NULL
(	NULL
HHV-8	NULL
)	NULL
DNA	NULL
sequences	NULL
,	NULL
as	NULL
well	NULL
as	NULL
BCL-2	NULL
rearrangements	NULL
,	NULL
have	NULL
also	NULL
been	NULL
described	NULL
.	NULL
``	NULL

''	NULL
``	NULL
``	NULL
Analysis	NULL
of	NULL
mutations	NULL
of	NULL
BCL-6	NULL
5	NULL
'	NULL
noncoding	NULL
regions	NULL
.	NULL

-	NULL
Analysis	NULL
of	NULL
mutations	NULL
of	NULL
BCL-6	NULL
5	NULL
'	NULL
noncoding	NULL
regions	NULL
was	NULL
performed	NULL
by	NULL
a	NULL
combination	NULL
of	NULL
polymerase	NULL
chain	NULL
reaction-single	NULL
strand	NULL
conformation	NULL
polymorphism	NULL
(	NULL
PCR-SSCP	NULL
)	NULL
and	NULL
DNA	NULL
direct	NULL
sequencing	NULL
.	NULL

PCR-SSCP	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
reported	NULL
.	NULL
``	NULL

Briefly	NULL
,	NULL
100	NULL
ng	NULL
of	NULL
genomic	NULL
DNA	NULL
,	NULL
10	NULL
pmol	NULL
of	NULL
each	NULL
primer	NULL
,	NULL
2.5	NULL
umol/L	NULL
deoxynucleotides	NULL
triphosphate	NULL
(	NULL
dNTPs	NULL
)	NULL
,	NULL
1	NULL
uCi	NULL
of	NULL
triphosphate	NULL
(	NULL
dCTP	NULL
)	NULL
(	NULL
Amersham	NULL
,	NULL
Rainham	NULL
,	NULL
UK	NULL
,	NULL
;	NULL
specific	NULL
activity	NULL
,	NULL
3,000	NULL
Ci/mmol	NULL
;	NULL
1	NULL
Ci	NULL
=	NULL
37	NULL
giga	NULL
becquerel	NULL
)	NULL
,	NULL
10	NULL
mmol/L	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
8.8	NULL
)	NULL
,	NULL
50	NULL
mmol/L	NULL
KCL	NULL
,	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

HISTOGENETIC	NULL
AND	NULL
PATHOGENETIC	NULL
FEATURES	NULL
OF	NULL
PCNSL	NULL
Fig	NULL
1	NULL
.	NULL

Genetic	NULL
analysis	NULL
of	NULL
BCL-6	NULL
5°	NULL
mutations	NULL
in	NULL
PCNSL	NULL
by	NULL
PCR-SSCP	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
and	NULL
DNA	NULL
direct	NULL
sequencing	NULL
(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
:	NULL
Representative	NULL
results	NULL
obtained	NULL
for	NULL
PCR	NULL
products	NULL
E1.10	NULL
(	NULL
A	NULL
)	NULL
and	NULL
E1.11	NULL
(	NULL
B	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

Samples	NULL
of	NULL
PCNSL	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
of	NULL
each	NULL
lane	NULL
by	NULL
a	NULL
numbered	NULL
code	NULL
.	NULL

A	NULL
positive	NULL
control	NULL
(	NULL
POS	NULL
)	NULL
,	NULL
represented	NULL
|	NULL
by	NULL
a	NULL
tumor	NULL
sample	NULL
known	NULL
to	NULL
har-	NULL
thous	NULL
|	NULL
bor	NULL
BCL-65¢	NULL
mutations	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
normal	NULL
(	NULL
N	NULL
)	NULL
sample	NULL
,	NULL
represented	NULL
by	NULL
a	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
,	NULL
are	NULL
also	NULL
included	NULL
for	NULL
each	NULL
PCR-SSCP	NULL
fragment	NULL
shown	NULL
.	NULL

Samples	NULL
were	NULL
scored	NULL
positive	NULL
when	NULL
their	NULL
migration	NULL
pattern	NULL
differed	NULL
from	NULL
the	NULL
normal	NULL
control	NULL
and	NULL
the	NULL
migration	NULL
abnormalities	NULL
could	NULL
not	NULL
be	NULL
ascribed	NULL
to	NULL
population	NULL
polymorphisms	NULL
.	NULL

Among	NULL
the	NULL
PCNSL	NULL
samples	NULL
shown	NULL
,	NULL
cases	NULL
scored	NULL
as	NULL
positive	NULL
included	NULL
cases	NULL
3	NULL
,	NULL
14	NULL
,	NULL
and	NULL
11	NULL
(	NULL
for	NULL
PCR	NULL
product	NULL
E1.10	NULL
)	NULL
;	NULL
8	NULL
,	NULL
28	NULL
,	NULL
and	NULL
47	NULL
(	NULL
for	NULL
PCR	NULL
product	NULL
E1.11	NULL
)	NULL
.	NULL

(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
:	NULL
Nucleotide	NULL
sequencing	NULL
analyses	NULL
of	NULL
BCL-6	NULL
5°	NULL
mutations	NULL
in	NULL
PCNSL	NULL
Load	NULL
E1.10	NULL
C	NULL
14	NULL
(	NULL
cases	NULL
14	NULL
,	NULL
43	NULL
,	NULL
and	NULL
47	NULL
)	NULL
.	NULL

The	NULL
se	NULL
-	NULL
A-	NULL
>	NULL
C	NULL
``	NULL
801	NULL
,	NULL
z	NULL
``	NULL
``	NULL
quence	NULL
of	NULL
each	NULL
PCNSL	NULL
case	NULL
is	NULL
Bo7	NULL
_	NULL
a	NULL
matched	NULL
either	NULL
to	NULL
the	NULL
sequence	NULL
of	NULL
T-	NULL
>	NULL
G	NULL
SL	NULL
,	NULL
``	NULL
a	NULL
normal	NULL
control	NULL
(	NULL
N	NULL
)	NULL
displaying	NULL
T-	NULL
>	NULL
C	NULL
m	NULL
)	NULL
Wi	NULL
®	NULL
germline	NULL
BCL-6	NULL
alleles	NULL
(	NULL
D	NULL
)	NULL
or	NULL
to	NULL
the	NULL
e	NULL
sequence	NULL
of	NULL
a	NULL
PCNSL	NULL
sample	NULL
har-	NULL
mat	NULL
boring	NULL
mutations	NULL
at	NULL
a	NULL
different	NULL
site	NULL
9°	NULL
e	NULL
822	NULL
(	NULL
C	NULL
)	NULL
.	NULL

The	NULL
position	NULL
of	NULL
mutations	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
nucleotide	NULL
number	NULL
of	NULL
the	NULL
corresponding	NULL
BCL-6	NULL
germline	NULL
sequence	NULL
(	NULL
the	NULL
first	NULL
nucleotide	NULL
of	NULL
the	NULL
BCL-6	NULL
cDNA	NULL
was	NULL
arbitrarily	NULL
chosen	NULL
as	NULL
position	NULL
+1	NULL
)	NULL
.	NULL

1	NULL
mmol/L	NULL
MgCl	NULL
;	NULL
,	NULL
0.01	NULL
%	NULL
gelatin	NULL
,	NULL
0.5	NULL
U	NULL
AmpliTaq	NULL
polymerase	NULL
(	NULL
Perkin-Elmer	NULL
,	NULL
Norwalk	NULL
,	NULL
CT	NULL
)	NULL
were	NULL
mixed	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
10	NULL
uL	NULL
.	NULL

Thirty	NULL
cycles	NULL
of	NULL
denaturation	NULL
(	NULL
94°C	NULL
)	NULL
,	NULL
annealing	NULL
(	NULL
annealing	NULL
temperatures	NULL
were	NULL
optimized	NULL
for	NULL
each	NULL
pair	NULL
of	NULL
primers	NULL
)	NULL
,	NULL
and	NULL
extension	NULL
(	NULL
72°C	NULL
)	NULL
were	NULL
performed	NULL
in	NULL
a	NULL
temperature	NULL
controller	NULL
(	NULL
DNA	NULL
Thermal	NULL
Cycler	NULL
,	NULL
Perkin-Elmer	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
heated	NULL
at	NULL
95°C	NULL
for	NULL
5	NULL
minutes	NULL
,	NULL
chilled	NULL
on	NULL
ice	NULL
,	NULL
and	NULL
immediately	NULL
loaded	NULL
(	NULL
3	NULL
uL	NULL
)	NULL
onto	NULL
a	NULL
6	NULL
%	NULL
acrylamide-tris-borate	NULL
EDTA	NULL
buffer	NULL
gel	NULL
containing	NULL
10	NULL
%	NULL
glycerol	NULL
.	NULL

Gels	NULL
were	NULL
run	NULL
at	NULL
8	NULL
W	NULL
for	NULL
12	NULL
to	NULL
15	NULL
hours	NULL
at	NULL
RT	NULL
,	NULL
fixed	NULL
in	NULL
10	NULL
%	NULL
acetic	NULL
acid	NULL
,	NULL
air	NULL
dried	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
autoradiography	NULL
using	NULL
an	NULL
intensifying	NULL
screen	NULL
for	NULL
6	NULL
to	NULL
72	NULL
hours	NULL
.	NULL

For	NULL
DNA	NULL
sequencing	NULL
of	NULL
BCL-6	NULL
5°	NULL
noncoding	NULL
regions	NULL
,	NULL
a	NULL
unique	NULL
PCR	NULL
product	NULL
encompassing	NULL
fragments	NULL
E1.10	NULL
,	NULL
E1.11	NULL
,	NULL
and	NULL
E1.12	NULL
(	NULL
nucleotides	NULL
+404	NULL
to	NULL
+1142	NULL
)	NULL
was	NULL
amplified	NULL
by	NULL
primers	NULL
E1.21B	NULL
and	NULL
E1.26	NULL
.	NULL

Direct	NULL
sequencing	NULL
of	NULL
the	NULL
amplified	NULL
PCR	NULL
fragment	NULL
was	NULL
performed	NULL
with	NULL
appropriate	NULL
primers	NULL
using	NULL
a	NULL
commercially	NULL
available	NULL
kit	NULL
(	NULL
ThermoSequenase	NULL
,	NULL
Amersham	NULL
Life	NULL
Sciences	NULL
,	NULL
Amersham	NULL
)	NULL
.	NULL

[	NULL
«	NULL
-	NULL
>	NULL
``	NULL
P	NULL
]	NULL
-labeled	NULL
terminator	NULL
dideoxynucleotides	NULL
were	NULL
included	NULL
in	NULL
the	NULL
sequencing	NULL
mixture	NULL
.	NULL

Both	NULL
strands	NULL
were	NULL
sequenced	NULL
for	NULL
each	NULL
DNA	NULL
fragment	NULL
analyzed	NULL
.	NULL

Molecular	NULL
analysis	NULL
of	NULL
clonality	NULL
and	NULL
other	NULL
genetic	NULL
lesions	NULL
.	NULL

The	NULL
organization	NULL
of	NULL
the	NULL
BCL-6	NULL
locus	NULL
was	NULL
analyzed	NULL
by	NULL
Southern	NULL
blot	NULL
analysis	NULL
hybridizing	NULL
BamHI	NULL
and	NULL
Xba	NULL
I	NULL
digested	NULL
DNA	NULL
to	NULL
the	NULL
human	NULL
BCL-6	NULL
probes	NULL
Sac	NULL
4.0	NULL
and	NULL
Sac	NULL
0.8	NULL
,	NULL
which	NULL
detect	NULL
the	NULL
cluster	NULL
of	NULL
BCL-6	NULL
rearrangements	NULL
of	NULL
NHL	NULL
.	NULL

*	NULL
``	NULL
The	NULL
status	NULL
of	NULL
the	NULL
c-MYC	NULL
locus	NULL
was	NULL
analyzed	NULL
by	NULL
a	NULL
combination	NULL
of	NULL
Southern	NULL
blot	NULL
analysis	NULL
and	NULL
mutational	NULL
studies	NULL
of	NULL
c-MYC	NULL
exonl-intron1	NULL
border	NULL
,	NULL
as	NULL
previously	NULL
reported	NULL
.	NULL
``	NULL

Analysis	NULL
of	NULL
BCL-2	NULL
rearrangements	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
.	NULL
``	NULL

''	NULL
PCR	NULL
«	NULL
--	NULL
-	NULL
qap	NULL
orp	NULL
o	NULL
--	NULL
GMP	NULL
Cup	NULL
--	NULL
43	NULL
A	NULL
G	NULL
CT	NULL
A	NULL
G	NULL
CT	NULL
1013	NULL
o	NULL
o	NULL
Fo	NULL
r	NULL
9	NULL
o	NULL
P	NULL
@	NULL
A4	NULL
g	NULL
a	NULL
C	NULL
go	NULL
as	NULL
wae	NULL
ms	NULL
L	NULL
Pila	NULL
c-	NULL
>	NULL
a	NULL
520	NULL
,	NULL
3-_	NULL
C_	NULL
kes	NULL
us	NULL
Ta	NULL
~~	NULL
*	NULL
z=	NULL
mnt	NULL
_	NULL
:	NULL
=	NULL
wee	NULL
-	NULL
CIs	NULL
_	NULL
__-=	NULL
_-	NULL
coa	NULL
501	NULL
,	NULL
=C	NULL
*~=	NULL
&	NULL
_	NULL
S5	NULL
wee	NULL
&	NULL
=___	NULL
g	NULL
®	NULL
_	NULL
_s30	NULL
I	NULL
s	NULL
oy	NULL
,	NULL
se	NULL
<	NULL
--	NULL
A	NULL
<	NULL
-	NULL
G	NULL
se	NULL
we	NULL
___	NULL
<	NULL
a-	NULL
eo	NULL
44	NULL
have	NULL
_	NULL
Sank	NULL
analysis	NULL
of	NULL
EBV	NULL
and	NULL
HHV-8	NULL
infection	NULL
were	NULL
also	NULL
performed	NULL
as	NULL
reported	NULL
previously	NULL
.	NULL
``	NULL

RESULTS	NULL
Characterization	NULL
of	NULL
the	NULL
tumor	NULL
panel	NULL
.	NULL

-	NULL
All	NULL
cases	NULL
of	NULL
AIDS-related	NULL
and	NULL
AIDS-unrelated	NULL
PCNSL	NULL
were	NULL
histologically	NULL
classified	NULL
as	NULL
B-DLCL	NULL
and	NULL
had	NULL
a	NULL
B-cell	NULL
phenotype	NULL
in	NULL
paraffin	NULL
sections	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
tumor	NULL
cell	NULL
positivity	NULL
for	NULL
CD45RA	NULL
,	NULL
CD20	NULL
,	NULL
and	NULL
CD74	NULL
and	NULL
negativity	NULL
for	NULL
CD45RO	NULL
,	NULL
CD3	NULL
,	NULL
and	NULL
CD57	NULL
.	NULL

Molecular	NULL
and/or	NULL
ISH	NULL
studies	NULL
demonstrated	NULL
the	NULL
monoclonality	NULL
of	NULL
all	NULL
cases	NULL
tested	NULL
(	NULL
n	NULL
=	NULL
47	NULL
;	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Characterization	NULL
of	NULL
BCL-6	NULL
molecular	NULL
alterations	NULL
in	NULL
PCNSL	NULL
.	NULL

All	NULL
cases	NULL
of	NULL
AIDS-related	NULL
and	NULL
AIDS-unrelated	NULL
PCNSL	NULL
were	NULL
investigated	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
mutations	NULL
of	NULL
the	NULL
5	NULL
'	NULL
noncoding	NULL
regions	NULL
of	NULL
BCL-6	NULL
.	NULL

Mutations	NULL
of	NULL
BCL-6	NULL
5	NULL
'	NULL
noncoding	NULL
regions	NULL
Table	NULL
1	NULL
.	NULL

Frequency	NULL
of	NULL
Genetic	NULL
Alterations	NULL
in	NULL
AIDS-Related	NULL
and	NULL
AIDS-Unrelated	NULL
PCNSL	NULL
BCL-6	NULL
Muta-	NULL
Rearrange	NULL
Tumor	NULL
tions	NULL
ments	NULL
c-MYC	NULL
BCL-2	NULL
EBV	NULL
-	NULL
HHV-8	NULL
AIDS-related	NULL
PCNSL	NULL
11/26	NULL
0/9	NULL
O/A	NULL
0/26	NULL
26/26	NULL
0/26	NULL
AIDS-unrelated	NULL
PCNSL	NULL
13/22	NULL
0/9	NULL
OA	NULL
0/22	NULL
0/22	NULL
0/22	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1014	NULL
Table	NULL
2	NULL
.	NULL

Characteristics	NULL
of	NULL
Mutations	NULL
of	NULL
the	NULL
5°	NULL
Noncoding	NULL
Regions	NULL
of	NULL
BCL-6	NULL
in	NULL
PCNSL	NULL
Sample	NULL
-	NULL
HIV	NULL
Mutation	NULL
(	NULL
position	NULL
)	NULL
*	NULL
15	NULL
+-	NULL
C-	NULL
G	NULL
(	NULL
444	NULL
)	NULL
,	NULL
T	NULL
-G	NULL
(	NULL
466	NULL
)	NULL
,	NULL
A	NULL
-	NULL
G	NULL
(	NULL
493	NULL
)	NULL
,	NULL
A	NULL
-	NULL
G	NULL
(	NULL
537	NULL
)	NULL
,	NULL
T	NULL
-	NULL
G	NULL
(	NULL
573	NULL
)	NULL
,	NULL
T	NULL
-	NULL
G	NULL
(	NULL
583	NULL
)	NULL
,	NULL
C-	NULL
G	NULL
(	NULL
616	NULL
)	NULL
,	NULL
a	NULL
-	NULL
T	NULL
(	NULL
730	NULL
)	NULL
14	NULL
+-	NULL
A	NULL
-C	NULL
(	NULL
801	NULL
)	NULL
,	NULL
T-	NULL
C	NULL
(	NULL
807	NULL
)	NULL
,	NULL
T	NULL
-	NULL
C	NULL
(	NULL
809	NULL
)	NULL
,	NULL
T	NULL
-C	NULL
(	NULL
822	NULL
)	NULL
42	NULL
00	NULL
--	NULL
G-	NULL
A	NULL
(	NULL
721	NULL
)	NULL
,	NULL
G-C	NULL
(	NULL
778	NULL
)	NULL
,	NULL
C-	NULL
G	NULL
(	NULL
843	NULL
)	NULL
,	NULL
+G	NULL
(	NULL
1096	NULL
)	NULL
,	NULL
T-	NULL
G	NULL
(	NULL
1102	NULL
)	NULL
,	NULL
G-	NULL
T	NULL
(	NULL
1103	NULL
)	NULL
43	NULL
-	NULL
-C-	NULL
G	NULL
(	NULL
769	NULL
)	NULL
,	NULL
a	NULL
-A	NULL
(	NULL
830	NULL
)	NULL
,	NULL
C-	NULL
G	NULL
(	NULL
879	NULL
)	NULL
44	NULL
_	NULL
-	NULL
_	NULL
G	NULL
-C	NULL
(	NULL
689	NULL
)	NULL
,	NULL
A	NULL
-G	NULL
(	NULL
698	NULL
)	NULL
,	NULL
G-	NULL
A	NULL
(	NULL
703	NULL
)	NULL
,	NULL
G-	NULL
A	NULL
(	NULL
714	NULL
)	NULL
,	NULL
G-	NULL
A	NULL
(	NULL
721	NULL
)	NULL
,	NULL
C-	NULL
T	NULL
(	NULL
767	NULL
)	NULL
39	NULL
-	NULL
-	NULL
aG	NULL
(	NULL
829	NULL
)	NULL
¢	NULL
49	NULL
-	NULL
-	NULL
G-	NULL
A	NULL
(	NULL
756	NULL
)	NULL
450	NULL
00	NULL
-_	NULL
C-	NULL
T	NULL
(	NULL
777	NULL
)	NULL
,	NULL
G-	NULL
T	NULL
(	NULL
977	NULL
)	NULL
47	NULL
_	NULL
-_	NULL
T	NULL
-C	NULL
(	NULL
461	NULL
)	NULL
,	NULL
G	NULL
-C	NULL
(	NULL
478	NULL
)	NULL
,	NULL
C-	NULL
A	NULL
(	NULL
501	NULL
)	NULL
,	NULL
C-	NULL
G	NULL
(	NULL
520	NULL
)	NULL
,	NULL
T-	NULL
A	NULL
(	NULL
546	NULL
)	NULL
,	NULL
G	NULL
-C	NULL
(	NULL
644	NULL
)	NULL
*The	NULL
first	NULL
nucleotide	NULL
of	NULL
the	NULL
BCL-6	NULL
cDNA	NULL
is	NULL
arbitrarily	NULL
chosen	NULL
as	NULL
position	NULL
+1	NULL
.	NULL

{	NULL
A	NULL
,	NULL
deletion	NULL
.	NULL

were	NULL
investigated	NULL
by	NULL
PCR-SSCP	NULL
analysis	NULL
of	NULL
three	NULL
PCR	NULL
fragments	NULL
encompassing	NULL
a	NULL
740-bp	NULL
region	NULL
containing	NULL
the	NULL
mutational	NULL
hot	NULL
spot	NULL
of	NULL
BCL-6	NULL
among	NULL
NHL	NULL
.	NULL

This	NULL
region	NULL
has	NULL
been	NULL
previously	NULL
shown	NULL
to	NULL
harbor	NULL
>	NULL
95	NULL
%	NULL
of	NULL
BCL-6	NULL
mutations	NULL
occurring	NULL
in	NULL
both	NULL
AIDS-related	NULL
and	NULL
AIDS-unrelated	NULL
systemic	NULL
NHL	NULL
.	NULL

``	NULL
*	NULL
``	NULL
*	NULL
The	NULL
PCNSL	NULL
samples	NULL
investigated	NULL
displayed	NULL
a	NULL
total	NULL
of	NULL
29	NULL
PCR-SSCP	NULL
LAROCCA	NULL
ET	NULL
AL	NULL
variants	NULL
,	NULL
which	NULL
were	NULL
unique	NULL
to	NULL
individual	NULL
tumor	NULL
samples	NULL
(	NULL
for	NULL
representative	NULL
results	NULL
,	NULL
see	NULL
Fig	NULL
1A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

As	NULL
described	NULL
previ-ously	NULL
,	NULL
cases	NULL
of	NULL
PCNSL	NULL
were	NULL
considered	NULL
positive	NULL
for	NULL
mutation	NULL
when	NULL
one	NULL
ore	NULL
more	NULL
PCR-SSCP	NULL
displayed	NULL
a	NULL
variant	NULL
pattern	NULL
,	NULL
which	NULL
could	NULL
not	NULL
be	NULL
ascribed	NULL
to	NULL
a	NULL
population	NULL
polymorphism	NULL
.	NULL

On	NULL
this	NULL
basis	NULL
,	NULL
mutations	NULL
of	NULL
BCL-6	NULL
were	NULL
scored	NULL
positive	NULL
in	NULL
24	NULL
of	NULL
48	NULL
(	NULL
50.0	NULL
%	NULL
)	NULL
PCNSL	NULL
,	NULL
including	NULL
11	NULL
of	NULL
26	NULL
(	NULL
42.3	NULL
%	NULL
)	NULL
AIDS-related	NULL
and	NULL
13	NULL
of	NULL
22	NULL
(	NULL
59.1	NULL
%	NULL
)	NULL
AIDS-unrelated	NULL
cases	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

In	NULL
selected	NULL
cases	NULL
,	NULL
mutations	NULL
were	NULL
further	NULL
characterized	NULL
by	NULL
DNA	NULL
sequencing	NULL
analysis	NULL
(	NULL
for	NULL
representative	NULL
results	NULL
,	NULL
see	NULL
Fig	NULL
1C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

The	NULL
characteristics	NULL
of	NULL
BCL-6	NULL
mutations	NULL
in	NULL
PCNSL	NULL
are	NULL
summarized	NULL
in	NULL
Table	NULL
2	NULL
.	NULL

Gross	NULL
rearrangements	NULL
of	NULL
BCL-6	NULL
were	NULL
investigated	NULL
in	NULL
selected	NULL
cases	NULL
(	NULL
n	NULL
=	NULL
18	NULL
;	NULL
nine	NULL
AIDS-related	NULL
and	NULL
nine	NULL
AIDS-unrelated	NULL
)	NULL
for	NULL
which	NULL
sufficient	NULL
cryopreserved	NULL
tissue	NULL
was	NULL
available	NULL
.	NULL

No	NULL
rearrangement	NULL
of	NULL
BCL-6	NULL
was	NULL
observed	NULL
among	NULL
the	NULL
cases	NULL
tested	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Characterization	NULL
of	NULL
other	NULL
genetic	NULL
lesions	NULL
.	NULL

Infection	NULL
by	NULL
EBV	NULL
was	NULL
detected	NULL
in	NULL
26	NULL
of	NULL
26	NULL
(	NULL
100	NULL
%	NULL
)	NULL
AIDS-related	NULL
PCNSL	NULL
and	NULL
was	NULL
negative	NULL
in	NULL
all	NULL
AIDS-unrelated	NULL
PCNSL	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Among	NULL
AIDS-related	NULL
PCNSL	NULL
,	NULL
ISH	NULL
studies	NULL
demonstrated	NULL
that	NULL
EBV	NULL
infection	NULL
was	NULL
harbored	NULL
by	NULL
the	NULL
neoplastic	NULL
cell	NULL
population	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

All	NULL
cases	NULL
of	NULL
AIDS-related	NULL
and	NULL
AIDS-unrelated	NULL
PCNSL	NULL
were	NULL
devoid	NULL
of	NULL
rearrangements	NULL
of	NULL
BCL-2	NULL
and	NULL
infection	NULL
by	NULL
HHV-8	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
all	NULL
tested	NULL
cases	NULL
(	NULL
n	NULL
=	NULL
18	NULL
;	NULL
9	NULL
AIDS	NULL
Table	NULL
3	NULL
.	NULL

Expression	NULL
of	NULL
LMP-1	NULL
,	NULL
BCL-6	NULL
,	NULL
BCL-2	NULL
,	NULL
and	NULL
hMSH2	NULL
in	NULL
AIDS-Related	NULL
and	NULL
AIDS-Unrelated	NULL
PCNSL	NULL
Diagnosis	NULL
Imm	NULL
unchistochem	NULL
istry	NULL
Case	NULL
HIV	NULL
REAL	NULL
WF	NULL
EBV*	NULL
LMP-1	NULL
(	NULL
%	NULL
)	NULL
BCL-6	NULL
(	NULL
%	NULL
)	NULL
BCL-2	NULL
(	NULL
%	NULL
)	NULL
hMSH2	NULL
(	NULL
%	NULL
)	NULL
1	NULL
+	NULL
DLCL	NULL
LNCCL	NULL
+	NULL
o	NULL
50-75	NULL
0	NULL
>	NULL
75	NULL
2	NULL
+	NULL
DLCL	NULL
LNCCL	NULL
+	NULL
o	NULL
25-50	NULL
0	NULL
>	NULL
75	NULL
3	NULL
+	NULL
DLCL	NULL
LNCCL	NULL
+	NULL
o	NULL
50-75	NULL
0	NULL
>	NULL
75	NULL
4	NULL
+	NULL
DLCL	NULL
LNCCL	NULL
+	NULL
o	NULL
25-50	NULL
0	NULL
50-75	NULL
5	NULL
+	NULL
DLCL	NULL
LNCCL	NULL
+	NULL
o	NULL
50-75	NULL
0	NULL
>	NULL
75	NULL
6	NULL
+	NULL
DLCL	NULL
LNCCL	NULL
+	NULL
o	NULL
10-25	NULL
0	NULL
50-75	NULL
7	NULL
+	NULL
DLCL	NULL
LNCCL	NULL
+	NULL
o	NULL
10-25	NULL
0	NULL
10-25	NULL
8	NULL
+	NULL
DLCL	NULL
IBPL	NULL
+	NULL
10-25	NULL
0	NULL
25-50	NULL
>	NULL
75	NULL
9	NULL
+	NULL
DLCL	NULL
IBPL	NULL
+	NULL
o	NULL
0	NULL
0	NULL
25-50	NULL
10	NULL
+	NULL
DLCL	NULL
IBPL	NULL
+	NULL
10-25	NULL
0	NULL
10-25	NULL
>	NULL
75	NULL
11	NULL
+	NULL
DLCL	NULL
IBPL	NULL
+	NULL
o	NULL
0	NULL
0	NULL
10-25	NULL
12	NULL
+	NULL
DLCL	NULL
IBPL	NULL
+	NULL
50-75	NULL
0	NULL
50-75	NULL
>	NULL
75	NULL
13	NULL
+	NULL
DLCL	NULL
IBPL	NULL
+	NULL
10-25	NULL
0	NULL
10-25	NULL
>	NULL
75	NULL
14	NULL
+	NULL
DLCL	NULL
IBPL	NULL
+	NULL
10-25	NULL
0	NULL
25-50	NULL
>	NULL
75	NULL
15	NULL
+	NULL
DLCL	NULL
LNCCL/IBPL	NULL
+	NULL
25-50	NULL
25-50	NULL
25-50	NULL
>	NULL
75	NULL
16	NULL
+	NULL
DLCL	NULL
LNCCL/IBPL	NULL
+	NULL
25-50	NULL
10-25	NULL
10-25	NULL
>	NULL
75	NULL
27	NULL
-	NULL
DLCL	NULL
LNCCL	NULL
-	NULL
0	NULL
25-50	NULL
0	NULL
>	NULL
75	NULL
28	NULL
-	NULL
DLCL	NULL
LNCCL	NULL
-	NULL
o	NULL
10-25	NULL
0	NULL
o	NULL
29	NULL
-	NULL
DLCL	NULL
LNCCL	NULL
-	NULL
o	NULL
10-25	NULL
0	NULL
>	NULL
75	NULL
30	NULL
-	NULL
DLCL	NULL
LNCCL	NULL
-	NULL
0	NULL
50-75	NULL
0	NULL
>	NULL
75	NULL
31	NULL
-	NULL
DLCL	NULL
LNCCL	NULL
-	NULL
o	NULL
>	NULL
75	NULL
0	NULL
>	NULL
75	NULL
32	NULL
-	NULL
DLCL	NULL
LNCCL	NULL
-	NULL
0	NULL
50-75	NULL
50-75	NULL
>	NULL
75	NULL
33	NULL
-	NULL
DLCL	NULL
LNCCL	NULL
-	NULL
o	NULL
10-25	NULL
0	NULL
>	NULL
75	NULL
34	NULL
-	NULL
DLCL	NULL
LNCCL	NULL
-	NULL
o	NULL
10-25	NULL
0	NULL
25-50	NULL
35	NULL
-	NULL
DLCL	NULL
LNCCL	NULL
-	NULL
0	NULL
50-75	NULL
0	NULL
>	NULL
75	NULL
36	NULL
-	NULL
DLCL	NULL
LNCCL	NULL
-	NULL
o	NULL
10-25	NULL
0	NULL
>	NULL
75	NULL
37	NULL
-	NULL
DLCL	NULL
LNCCL	NULL
-	NULL
0	NULL
50-75	NULL
10-25	NULL
>	NULL
75	NULL
38	NULL
-	NULL
DLCL	NULL
LNCCL	NULL
-	NULL
0	NULL
25-50	NULL
0	NULL
>	NULL
75	NULL
39	NULL
-	NULL
DLCL	NULL
LNCCL	NULL
-	NULL
0	NULL
25-50	NULL
0	NULL
>	NULL
75	NULL
40	NULL
-	NULL
DLCL	NULL
LNCCL	NULL
-	NULL
0	NULL
50-75	NULL
0	NULL
50-75	NULL
Abbreviations	NULL
:	NULL
REAL	NULL
,	NULL
Revised	NULL
European-American	NULL
Lymphoma	NULL
classification	NULL
;	NULL
WF	NULL
,	NULL
Working	NULL
Formulation	NULL
.	NULL

*	NULL
EBV	NULL
status	NULL
as	NULL
defined	NULL
by	NULL
EBER	NULL
ISH	NULL
studies	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

HISTOGENETIC	NULL
AND	NULL
PATHOGENETIC	NULL
FEATURES	NULL
OF	NULL
PCNSL	NULL
'	NULL
&	NULL
4	NULL
#	NULL
.	NULL

?	NULL

“	NULL
3	NULL
p	NULL
f	NULL
W	NULL
#	NULL
12	NULL
,	NULL
ix	NULL
,	NULL
C	NULL
A	NULL
%	NULL
§	NULL
&	NULL
P	NULL
*	NULL
%	NULL
6	NULL
Cie	NULL
(	NULL
C	NULL
Fig	NULL
2	NULL
.	NULL

LMP-1	NULL
expression	NULL
in	NULL
a	NULL
case	NULL
of	NULL
AIDS-related	NULL
PCNSL	NULL
(	NULL
DLCL	NULL
}	NULL
.	NULL

The	NULL
microphotograph	NULL
shows	NULL
that	NULL
the	NULL
tumor	NULL
is	NULL
polymorphous	NULL
and	NULL
predominantly	NULL
consists	NULL
of	NULL
large	NULL
tumor	NULL
cells	NULL
displaying	NULL
an	NULL
immunoblas-tic-plasmacytoid	NULL
morphology	NULL
.	NULL

LMP-1	NULL
positivity	NULL
is	NULL
evident	NULL
as	NULL
cytoplasmic	NULL
staining	NULL
in	NULL
some	NULL
large	NULL
tumor	NULL
cells	NULL
.	NULL

Paraffin-embedded	NULL
tissue	NULL
section	NULL
,	NULL
APAAP	NULL
immunostaining	NULL
,	NULL
hematoxylin	NULL
counterstain	NULL
.	NULL

Original	NULL
magnification	NULL
x	NULL
630	NULL
.	NULL

Fig	NULL
4	NULL
.	NULL

BCL-6	NULL
protein	NULL
expression	NULL
in	NULL
a	NULL
case	NULL
of	NULL
AIDS-related	NULL
PCNSL	NULL
(	NULL
DLCL	NULL
)	NULL
.	NULL

The	NULL
microphotograph	NULL
shows	NULL
that	NULL
the	NULL
tumor	NULL
is	NULL
relatively	NULL
monomorphous	NULL
and	NULL
predominantly	NULL
consists	NULL
of	NULL
large	NULL
tumor	NULL
cells	NULL
displaying	NULL
a	NULL
large	NULL
noncleaved	NULL
cell	NULL
morphology	NULL
.	NULL

Several	NULL
tumor	NULL
cells	NULL
display	NULL
the	NULL
characteristic	NULL
nuclear	NULL
positivity	NULL
for	NULL
BCL-6	NULL
.	NULL

Paraffin-embedded	NULL
tissue	NULL
section	NULL
,	NULL
APAAP	NULL
immunostaining	NULL
,	NULL
hematoxylin	NULL
counterstain	NULL
.	NULL

Original	NULL
magnification	NULL
x	NULL
250	NULL
.	NULL

1015	NULL
L	NULL
``	NULL
t	NULL
dr	NULL
dx	NULL
Fig	NULL
3	NULL
.	NULL

BCL-2	NULL
protein	NULL
expression	NULL
in	NULL
a	NULL
case	NULL
of	NULL
AIDS-related	NULL
PCNSL	NULL
(	NULL
DLCL	NULL
)	NULL
.	NULL

The	NULL
microphotograph	NULL
show	NULL
s	NULL
that	NULL
the	NULL
tumor	NULL
consists	NULL
of	NULL
large	NULL
tumor	NULL
cells	NULL
with	NULL
immunoblastic	NULL
morphology	NULL
.	NULL

BCL-2	NULL
positivity	NULL
is	NULL
manifested	NULL
as	NULL
cytoplasmic	NULL
staining	NULL
in	NULL
several	NULL
tumor	NULL
cells	NULL
.	NULL

Paraffin-embedded	NULL
tissue	NULL
section	NULL
,	NULL
ABC-px	NULL
immunostaining	NULL
and	NULL
tyramide	NULL
amplification	NULL
,	NULL
hematoxylin	NULL
counterstain	NULL
.	NULL

Original	NULL
magnification	NULL
x	NULL
250	NULL
.	NULL

Fig	NULL
5	NULL
.	NULL

AIDS-related	NULL
PCNSL	NULL
(	NULL
DLCL	NULL
)	NULL
.	NULL

Two-color	NULL
staining	NULL
.	NULL

(	NULL
A	NULL
)	NULL
In	NULL
this	NULL
microphotograph	NULL
,	NULL
several	NULL
tumor	NULL
cells	NULL
exhibit	NULL
nuclear	NULL
staining	NULL
(	NULL
blue	NULL
)	NULL
for	NULL
BCL-6	NULL
and	NULL
few	NULL
cells	NULL
show	NULL
a	NULL
strong	NULL
cytoplasmic	NULL
and	NULL
membrane	NULL
staining	NULL
(	NULL
reddish	NULL
)	NULL
for	NULL
LMP-1	NULL
.	NULL

No	NULL
coexpression	NULL
of	NULL
both	NULL
markers	NULL
by	NULL
the	NULL
same	NULL
tumor	NULL
cell	NULL
is	NULL
detectable	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Microphotograph	NULL
of	NULL
a	NULL
different	NULL
field	NULL
in	NULL
which	NULL
there	NULL
is	NULL
a	NULL
prevalence	NULL
of	NULL
LMP-1+	NULL
cells	NULL
with	NULL
few	NULL
BCL-6+	NULL
nuclei	NULL
.	NULL

No	NULL
coexpression	NULL
is	NULL
detectable	NULL
.	NULL

Paraffin-embedded	NULL
tissue	NULL
section	NULL
,	NULL
no	NULL
counterstain	NULL
.	NULL

Original	NULL
magnification	NULL
x	NULL
400	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1016	NULL
related	NULL
and	NULL
9	NULL
AIDS-unrelated	NULL
)	NULL
were	NULL
devoid	NULL
of	NULL
molecular	NULL
alterations	NULL
of	NULL
c-MYC	NULL
,	NULL
including	NULL
both	NULL
gross	NULL
rearrangements	NULL
and	NULL
mutations	NULL
of	NULL
the	NULL
regulatory	NULL
regions	NULL
of	NULL
the	NULL
proto-oncogene	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
BCL-6	NULL
,	NULL
LMP-1	NULL
,	NULL
and	NULL
BCL-2	NULL
in	NULL
AIDS-related	NULL
PCNSL	NULL
.	NULL

-	NULL
Results	NULL
are	NULL
summarized	NULL
in	NULL
Table	NULL
3	NULL
.	NULL

All	NULL
AIDS-related	NULL
PCNSL	NULL
carried	NULL
EBV	NULL
infection	NULL
of	NULL
the	NULL
tumor	NULL
clone	NULL
.	NULL

Expression	NULL
of	NULL
LMP-1	NULL
was	NULL
detected	NULL
in	NULL
seven	NULL
of	NULL
16	NULL
(	NULL
43.7	NULL
%	NULL
)	NULL
cases	NULL
.	NULL

In	NULL
cases	NULL
scored	NULL
positive	NULL
,	NULL
both	NULL
the	NULL
membrane	NULL
surface	NULL
and	NULL
the	NULL
cytoplasm	NULL
of	NULL
the	NULL
neoplastic	NULL
cells	NULL
stained	NULL
positive	NULL
for	NULL
LMP-1	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

All	NULL
LMP-1+*	NULL
PCNSL	NULL
also	NULL
expressed	NULL
BCL-2	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
,	NULL
while	NULL
all	NULL
LMP-1~	NULL
cases	NULL
failed	NULL
to	NULL
express	NULL
BCL-2	NULL
.	NULL

Expression	NULL
of	NULL
BCL-6	NULL
was	NULL
detected	NULL
in	NULL
9	NULL
of	NULL
16	NULL
(	NULL
56.2	NULL
%	NULL
)	NULL
AIDS-related	NULL
PCNSL	NULL
.	NULL

Positivity	NULL
for	NULL
BCL-6	NULL
was	NULL
nuclear	NULL
and	NULL
displayed	NULL
a	NULL
microgranular	NULL
pattern	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

The	NULL
majority	NULL
of	NULL
BCL-6*	NULL
cases	NULL
(	NULL
7	NULL
of	NULL
9	NULL
)	NULL
failed	NULL
to	NULL
express	NULL
LMP-1	NULL
and	NULL
BCL-2	NULL
.	NULL

On	NULL
this	NULL
basis	NULL
,	NULL
two	NULL
major	NULL
phenotypic	NULL
profiles	NULL
could	NULL
be	NULL
identified	NULL
among	NULL
AIDS-related	NULL
PCNSL	NULL
,	NULL
ie	NULL
,	NULL
BCL-6*/LMP-1~/BCL-2~	NULL
and	NULL
BCL-6~/LMP-1*/BCL-2+	NULL
.	NULL

The	NULL
phenotypic	NULL
profile	NULL
displayed	NULL
by	NULL
each	NULL
individual	NULL
AIDS-PCNSL	NULL
was	NULL
compared	NULL
with	NULL
the	NULL
morphologic	NULL
features	NULL
of	NULL
the	NULL
tumors	NULL
,	NULL
which	NULL
had	NULL
been	NULL
assessed	NULL
independently	NULL
without	NULL
knowledge	NULL
of	NULL
the	NULL
results	NULL
of	NULL
phenotypic	NULL
studies	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
a	NULL
predominance	NULL
(	NULL
>	NULL
80	NULL
%	NULL
)	NULL
of	NULL
tumor	NULL
cells	NULL
with	NULL
immunoblastic	NULL
features	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
for	NULL
details	NULL
)	NULL
,	NULL
cases	NULL
were	NULL
classified	NULL
as	NULL
LNCCL	NULL
or	NULL
IBPL	NULL
.	NULL

Seven	NULL
of	NULL
seven	NULL
(	NULL
100	NULL
%	NULL
)	NULL
cases	NULL
displaying	NULL
the	NULL
BCL-6+*+/LMP-1-/BCL-2~	NULL
phenotype	NULL
were	NULL
classified	NULL
as	NULL
LNCCL	NULL
(	NULL
Table	NULL
3	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
five	NULL
of	NULL
seven	NULL
(	NULL
71.0	NULL
%	NULL
)	NULL
cases	NULL
displaying	NULL
the	NULL
BCL-6-/LMP-1*/BCL-2+*	NULL
phenotype	NULL
were	NULL
classified	NULL
as	NULL
IBPL	NULL
(	NULL
Table	NULL
3	NULL
)	NULL
.	NULL

Two	NULL
cases	NULL
of	NULL
AIDS-related	NULL
PCNSL	NULL
(	NULL
cases	NULL
15	NULL
and	NULL
16	NULL
;	NULL
Table	NULL
3	NULL
)	NULL
were	NULL
found	NULL
to	NULL
express	NULL
BCL-6	NULL
,	NULL
LMP-1	NULL
,	NULL
and	NULL
BCL-2	NULL
.	NULL

However	NULL
,	NULL
double-staining	NULL
studies	NULL
ruled	NULL
out	NULL
the	NULL
coexpression	NULL
of	NULL
BCL-6	NULL
and	NULL
LMP-1	NULL
by	NULL
the	NULL
same	NULL
neoplastic	NULL
cell	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

These	NULL
two	NULL
AIDS-related	NULL
PCNSL	NULL
were	NULL
composed	NULL
of	NULL
an	NULL
admixture	NULL
of	NULL
immunoblasts	NULL
and	NULL
tumor	NULL
cells	NULL
displaying	NULL
an	NULL
LNCCL	NULL
morphology	NULL
and	NULL
were	NULL
classified	NULL
separately	NULL
as	NULL
LNCCL/IBPL	NULL
.	NULL

When	NULL
referring	NULL
to	NULL
the	NULL
updated	NULL
Kiel	NULL
classification	NULL
,	NULL
``	NULL
``	NULL
these	NULL
two	NULL
cases	NULL
were	NULL
consistent	NULL
with	NULL
the	NULL
diagnosis	NULL
of	NULL
centroblastic	NULL
polymorphic	NULL
lymphomas	NULL
.	NULL

Expression	NULL
of	NULL
BCL-6	NULL
,	NULL
LMP-1	NULL
,	NULL
and	NULL
BCL	NULL
-2	NULL
in	NULL
AIDS-unrelated	NULL
PCNSL	NULL
.	NULL

Results	NULL
are	NULL
summarized	NULL
in	NULL
Table	NULL
3	NULL
.	NULL

All	NULL
AIDS-unrelated	NULL
PCNSL	NULL
were	NULL
devoid	NULL
of	NULL
EBV	NULL
infection	NULL
and	NULL
,	NULL
conse-quently	NULL
,	NULL
did	NULL
not	NULL
express	NULL
LMP-1	NULL
(	NULL
Tables	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
BCL-6	NULL
was	NULL
detected	NULL
in	NULL
14	NULL
of	NULL
14	NULL
(	NULL
100	NULL
%	NULL
)	NULL
AIDS-unrelated	NULL
PCNSL	NULL
.	NULL

Positivity	NULL
for	NULL
BCL-6	NULL
was	NULL
nuclear	NULL
and	NULL
displayed	NULL
a	NULL
microgranular	NULL
pattern	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
BCL-2	NULL
was	NULL
restricted	NULL
to	NULL
2	NULL
of	NULL
14	NULL
cases	NULL
(	NULL
14.3	NULL
%	NULL
)	NULL
.	NULL

All	NULL
AIDS-unrelated	NULL
PCNSL	NULL
were	NULL
histologically	NULL
classified	NULL
as	NULL
LNCCL	NULL
.	NULL

Comparison	NULL
between	NULL
BCL-6	NULL
protein	NULL
expression	NULL
and	NULL
mutation	NULL
of	NULL
BCL-6	NULL
5	NULL
'	NULL
noncoding	NULL
regions	NULL
in	NULL
PCNSL	NULL
.	NULL

-	NULL
Similiar	NULL
to	NULL
systemic	NULL
lymphomas	NULL
of	NULL
HIV-infected	NULL
individuals	NULL
,	NULL
``	NULL
expression	NULL
of	NULL
BCL	NULL
-6	NULL
protein	NULL
was	NULL
found	NULL
to	NULL
occur	NULL
both	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
mutations	NULL
of	NULL
BCL-6	NULL
5	NULL
'	NULL
noncoding	NULL
regions	NULL
.	NULL

When	NULL
considering	NULL
cases	NULL
investigated	NULL
for	NULL
both	NULL
mutations	NULL
and	NULL
protein	NULL
expression	NULL
of	NULL
BCL-6	NULL
,	NULL
mutations	NULL
of	NULL
BCL-6	NULL
5	NULL
'	NULL
noncoding	NULL
regions	NULL
occurred	NULL
in	NULL
10	NULL
of	NULL
22	NULL
(	NULL
45.4	NULL
%	NULL
)	NULL
PCNSL	NULL
expressing	NULL
the	NULL
BCL-6	NULL
protein	NULL
,	NULL
including	NULL
4	NULL
of	NULL
9	NULL
(	NULL
44.4	NULL
%	NULL
)	NULL
AIDS-related	NULL
PCNSL	NULL
and	NULL
6	NULL
of	NULL
13	NULL
(	NULL
46.2	NULL
%	NULL
)	NULL
AIDS-unrelated	NULL
PCNSL	NULL
.	NULL

However	NULL
,	NULL
because	NULL
the	NULL
immunohistochemistry	NULL
technique	NULL
used	NULL
for	NULL
BCL-6	NULL
protein	NULL
detec-	NULL
LAROCCA	NULL
ET	NULL
AL	NULL
tion	NULL
does	NULL
not	NULL
allow	NULL
quantitation	NULL
of	NULL
the	NULL
cellular	NULL
levels	NULL
of	NULL
the	NULL
protein	NULL
,	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
assess	NULL
variations	NULL
,	NULL
if	NULL
any	NULL
,	NULL
of	NULL
the	NULL
BCL-6	NULL
expression	NULL
levels	NULL
in	NULL
PCNSL	NULL
harboring	NULL
BCL-6	NULL
mutations	NULL
as	NULL
compared	NULL
with	NULL
cases	NULL
devoid	NULL
of	NULL
mutations	NULL
.	NULL

Expression	NULL
of	NULL
hMSH2	NULL
in	NULL
AIDS-related	NULL
and	NULL
AIDS-unrelated	NULL
PCNSL	NULL
.	NULL

-	NULL
hMSH2	NULL
is	NULL
a	NULL
DNA	NULL
mismatch	NULL
repair	NULL
enzyme	NULL
located	NULL
in	NULL
the	NULL
nucleus	NULL
and	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
of	NULL
fidelity	NULL
of	NULL
genomic	NULL
replication	NULL
.	NULL
``	NULL

''	NULL
Expression	NULL
of	NULL
hMSH2	NULL
has	NULL
been	NULL
studied	NULL
extensively	NULL
in	NULL
epithelial	NULL
tissues	NULL
and	NULL
cancers	NULL
,	NULL
whereas	NULL
its	NULL
expression	NULL
pattern	NULL
in	NULL
normal	NULL
and	NULL
neoplastic	NULL
lymphoid	NULL
tissues	NULL
is	NULL
un-known.4'**	NULL
Evidence	NULL
obtained	NULL
by	NULL
one	NULL
of	NULL
us	NULL
(	NULL
L.M.L	NULL
,	NULL
unpublished	NULL
observation	NULL
)	NULL
had	NULL
suggested	NULL
that	NULL
hMSH2	NULL
expression	NULL
among	NULL
mature	NULL
B-cell	NULL
subsets	NULL
clusters	NULL
with	NULL
GC	NULL
cells	NULL
,	NULL
thus	NULL
prompting	NULL
our	NULL
analysis	NULL
of	NULL
this	NULL
protein	NULL
among	NULL
PCNSL	NULL
.	NULL

Immunoreactivity	NULL
for	NULL
the	NULL
anti-hMSH2	NULL
MoAb	NULL
was	NULL
scored	NULL
using	NULL
the	NULL
criteria	NULL
described	NULL
above	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Figure	NULL
6	NULL
shows	NULL
that	NULL
hMSH2	NULL
is	NULL
a	NULL
nuclear	NULL
located	NULL
protein	NULL
that	NULL
in	NULL
normal	NULL
mature	NULL
lymphoid	NULL
tissues	NULL
is	NULL
selectively	NULL
expressed	NULL
by	NULL
follicular	NULL
GC	NULL
B	NULL
cells	NULL
;	NULL
the	NULL
mantle	NULL
,	NULL
paracortical	NULL
,	NULL
and	NULL
marginal	NULL
zones	NULL
score	NULL
negative	NULL
for	NULL
hMSH2	NULL
expression	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
isolated	NULL
large	NULL
cells	NULL
(	NULL
Fig	NULL
6A	NULL
through	NULL
D	NULL
)	NULL
.	NULL

Among	NULL
PCNSL	NULL
,	NULL
hMSH2	NULL
protein	NULL
was	NULL
expressed	NULL
by	NULL
29	NULL
of	NULL
30	NULL
(	NULL
96.7	NULL
%	NULL
)	NULL
tested	NULL
cases	NULL
,	NULL
including	NULL
16	NULL
of	NULL
16	NULL
(	NULL
100	NULL
%	NULL
)	NULL
AIDS-related	NULL
and	NULL
13	NULL
of	NULL
14	NULL
(	NULL
92.8	NULL
%	NULL
)	NULL
AIDS-unrelated	NULL
cases	NULL
.	NULL

The	NULL
staining	NULL
pattern	NULL
was	NULL
nuclear	NULL
and	NULL
of	NULL
moderate	NULL
intensity	NULL
(	NULL
Fig	NULL
6E	NULL
)	NULL
.	NULL

DISCUSSION	NULL
The	NULL
aim	NULL
of	NULL
this	NULL
study	NULL
was	NULL
to	NULL
characterize	NULL
the	NULL
histogenesis	NULL
and	NULL
pathogenesis	NULL
of	NULL
the	NULL
clinicopathologic	NULL
spectrum	NULL
of	NULL
PCNSL	NULL
,	NULL
including	NULL
AIDS-related	NULL
and	NULL
AIDS-unrelated	NULL
cases	NULL
.	NULL

The	NULL
results	NULL
indicate	NULL
that	NULL
PCNSL	NULL
frequently	NULL
associate	NULL
with	NULL
molecular	NULL
and	NULL
phenotypic	NULL
features	NULL
consistent	NULL
with	NULL
GC	NULL
B-cell	NULL
phenotype	NULL
,	NULL
suggesting	NULL
that	NULL
a	NULL
large	NULL
fraction	NULL
of	NULL
PCNSL	NULL
may	NULL
be	NULL
histogenetically	NULL
related	NULL
to	NULL
GC	NULL
B	NULL
cell	NULL
.	NULL

Differential	NULL
expression	NULL
of	NULL
BCL-6	NULL
,	NULL
BCL-2	NULL
,	NULL
and	NULL
LMP-1	NULL
segregates	NULL
distinct	NULL
phenotypic	NULL
patterns	NULL
,	NULL
which	NULL
preferentially	NULL
associate	NULL
with	NULL
specific	NULL
morphologic	NULL
variants	NULL
of	NULL
the	NULL
disease	NULL
.	NULL

These	NULL
findings	NULL
may	NULL
bear	NULL
implications	NULL
for	NULL
the	NULL
classification	NULL
and	NULL
diagnosis	NULL
of	NULL
PCNSL	NULL
.	NULL

Our	NULL
molecular	NULL
analysis	NULL
indicates	NULL
that	NULL
mutations	NULL
of	NULL
the	NULL
5	NULL
'	NULL
noncoding	NULL
regions	NULL
of	NULL
BCL-6	NULL
represent	NULL
the	NULL
most	NULL
frequent	NULL
proto-oncogene	NULL
lesion	NULL
presently	NULL
detectable	NULL
among	NULL
PCNSL	NULL
.	NULL

The	NULL
relevance	NULL
of	NULL
this	NULL
finding	NULL
is	NULL
threefold	NULL
.	NULL

First	NULL
,	NULL
mutations	NULL
of	NULL
BCL-6	NULL
5	NULL
'	NULL
noncoding	NULL
regions	NULL
are	NULL
regarded	NULL
as	NULL
a	NULL
genetic	NULL
marker	NULL
specifically	NULL
acquired	NULL
by	NULL
B	NULL
cells	NULL
at	NULL
the	NULL
time	NULL
of	NULL
transition	NULL
through	NULL
the	NULL
GC	NULL
,	NULL
whereas	NULL
they	NULL
are	NULL
rare	NULL
or	NULL
absent	NULL
in	NULL
B-cell	NULL
subsets	NULL
that	NULL
have	NULL
not	NULL
transited	NULL
through	NULL
the	NULL
On	NULL
this	NULL
basis	NULL
,	NULL
the	NULL
frequent	NULL
occurrence	NULL
of	NULL
BCL-6	NULL
mutations	NULL
among	NULL
PCNSL	NULL
suggests	NULL
that	NULL
a	NULL
substantial	NULL
fraction	NULL
of	NULL
these	NULL
tumors	NULL
may	NULL
derive	NULL
from	NULL
B	NULL
cells	NULL
related	NULL
to	NULL
the	NULL
GC	NULL
and	NULL
localized	NULL
subsequently	NULL
to	NULL
the	NULL
CNS	NULL
.	NULL

Second	NULL
,	NULL
the	NULL
frequency	NULL
of	NULL
BCL-6	NULL
mutations	NULL
and	NULL
their	NULL
location	NULL
in	NULL
the	NULL
proximity	NULL
of	NULL
the	NULL
BCL-6	NULL
promoter	NULL
suggest	NULL
that	NULL
these	NULL
mutations	NULL
may	NULL
have	NULL
been	NULL
selected	NULL
during	NULL
tumorigenesis	NULL
based	NULL
on	NULL
their	NULL
potential	NULL
ability	NULL
to	NULL
deregulate	NULL
BCL-6	NULL
expression	NULL
,	NULL
as	NULL
also	NULL
indicated	NULL
by	NULL
data	NULL
obtained	NULL
from	NULL
in	NULL
vitro	NULL
models	NULL
.	NULL

*	NULL
Third	NULL
,	NULL
the	NULL
frequency	NULL
and	NULL
tumor	NULL
specificity	NULL
of	NULL
BCL-6	NULL
mutations	NULL
among	NULL
PCNSL	NULL
suggest	NULL
that	NULL
these	NULL
lesions	NULL
may	NULL
prove	NULL
to	NULL
be	NULL
a	NULL
valuable	NULL
marker	NULL
for	NULL
the	NULL
molecular	NULL
monitoring	NULL
of	NULL
the	NULL
disease	NULL
.	NULL

It	NULL
is	NULL
curious	NULL
that	NULL
,	NULL
despite	NULL
the	NULL
frequent	NULL
rate	NULL
of	NULL
BCL-6	NULL
mutations	NULL
,	NULL
PCNSL	NULL
appear	NULL
to	NULL
be	NULL
devoid	NULL
of	NULL
BCL-6	NULL
rearrangements	NULL
,	NULL
From	NULL
HISTOGENETIC	NULL
AND	NULL
PATHOGENETIC	NULL
FEATURES	NULL
OF	NULL
PCNSL	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

1017	NULL
Fig	NULL
6.	NULL
hMSH2	NULL
expression	NULL
in	NULL
reactive	NULL
secondary	NULL
B-cell	NULL
follicle	NULL
in	NULL
lymphnode	NULL
(	NULL
A	NULL
)	NULL
,	NULL
spleen	NULL
(	NULL
B	NULL
)	NULL
,	NULL
appendix	NULL
(	NULL
C	NULL
)	NULL
,	NULL
and	NULL
palatine	NULL
tonsil	NULL
(	NULL
D	NULL
)	NULL
.	NULL

hMSH2	NULL
is	NULL
a	NULL
nuclear	NULL
located	NULL
protein	NULL
selectively	NULL
expressed	NULL
by	NULL
follicular	NULL
germinal	NULL
center	NULL
B	NULL
cell	NULL
;	NULL
the	NULL
mantle	NULL
,	NULL
paracortical	NULL
,	NULL
and	NULL
marginal	NULL
zones	NULL
appear	NULL
hMSH2	NULL
negative	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
large	NULL
secondary	NULL
blasts	NULL
that	NULL
are	NULL
crossing	NULL
the	NULL
mantle	NULL
.	NULL

(	NULL
E	NULL
)	NULL
AIDS-related	NULL
PCNSL	NULL
;	NULL
(	NULL
F	NULL
)	NULL
AIDS-unrelated	NULL
PCNSL	NULL
.	NULL

Most	NULL
neoplastic	NULL
cells	NULL
show	NULL
a	NULL
nuclear	NULL
staining	NULL
pattern	NULL
with	NULL
anti-hMSH2	NULL
MoAb	NULL
.	NULL

Paraffin-embedded	NULL
tissue	NULL
section	NULL
,	NULL
ABC-px	NULL
immunostaining	NULL
,	NULL
hematoxylin	NULL
counterstain	NULL
.	NULL

Original	NULL
magnification	NULL
x	NULL
100	NULL
(	NULL
A	NULL
)	NULL
,	NULL
(	NULL
B	NULL
)	NULL
,	NULL
x	NULL
250	NULL
(	NULL
Cthrough	NULL
F	NULL
)	NULL
.	NULL

which	NULL
occur	NULL
in	NULL
approximately	NULL
30	NULL
%	NULL
to	NULL
40	NULL
%	NULL
of	NULL
systemic	NULL
DLCL	NULL
of	NULL
the	NULL
immunocompetent	NULL
host	NULL
and	NULL
in	NULL
15	NULL
%	NULL
to	NULL
20	NULL
%	NULL
of	NULL
AIDS-related	NULL
DLCL	NULL
.	NULL

``	NULL
``	NULL
>	NULL
4°	NULL
The	NULL
reason	NULL
for	NULL
the	NULL
absence	NULL
of	NULL
BCL-6	NULL
rearrangements	NULL
among	NULL
AIDS-related	NULL
and	NULL
AIDS-unrelated	NULL
PCNSL	NULL
remains	NULL
unexplained	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
combination	NULL
of	NULL
BCL-6	NULL
mutations	NULL
and	NULL
EBV	NULL
infection	NULL
may	NULL
be	NULL
sufficient	NULL
for	NULL
PCNSL	NULL
development	NULL
in	NULL
the	NULL
context	NULL
of	NULL
AIDS	NULL
,	NULL
whereas	NULL
an	NULL
additional	NULL
,	NULL
presently	NULL
unknown	NULL
,	NULL
genetic	NULL
alteration	NULL
may	NULL
substitute	NULL
for	NULL
EBV	NULL
in	NULL
AIDS-unrelated	NULL
PCNSL	NULL
.	NULL

The	NULL
notion	NULL
that	NULL
PCNSL	NULL
are	NULL
histogenetically	NULL
related	NULL
to	NULL
GC	NULL
B	NULL
cells	NULL
is	NULL
further	NULL
corroborated	NULL
by	NULL
our	NULL
observation	NULL
that	NULL
PCNSL	NULL
frequently	NULL
express	NULL
the	NULL
BCL-6	NULL
protein	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
BCL-6	NULL
expression	NULL
clusters	NULL
with	NULL
GC	NULL
B	NULL
cells	NULL
throughout	NULL
physiologic	NULL
B-cell	NULL
differentiation	NULL
.	NULL
``	NULL

Whereas	NULL
all	NULL
AIDS-unrelated	NULL
PCNSL	NULL
score	NULL
positive	NULL
for	NULL
BCL-6	NULL
expression	NULL
,	NULL
AIDS-related	NULL
PCNSL	NULL
display	NULL
a	NULL
certain	NULL
degree	NULL
of	NULL
heterogeneity	NULL
.	NULL

Notably	NULL
,	NULL
expression	NULL
of	NULL
BCL-6	NULL
is	NULL
absent	NULL
in	NULL
AIDS-related	NULL
PCNSL	NULL
expressing	NULL
the	NULL
EBV-encoded	NULL
LMP-1	NULL
antigen	NULL
.	NULL

The	NULL
mutually	NULL
exclusive	NULL
expression	NULL
of	NULL
BCL-6	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1018	NULL
and	NULL
LMP-1	NULL
observed	NULL
among	NULL
AIDS-related	NULL
PCNSL	NULL
is	NULL
reminiscent	NULL
of	NULL
that	NULL
detected	NULL
among	NULL
systemic	NULL
AIDS-related	NULL
NHL	NULL
and	NULL
is	NULL
consistent	NULL
with	NULL
data	NULL
derived	NULL
from	NULL
in	NULL
vitro	NULL
models	NULL
suggesting	NULL
that	NULL
LMP-1	NULL
is	NULL
able	NULL
to	NULL
downregulate	NULL
BCL-6	NULL
.	NULL
``	NULL

Consistent	NULL
with	NULL
the	NULL
fact	NULL
that	NULL
LMP-1	NULL
upregulates	NULL
BCL-2	NULL
,	NULL
BCL-6-/LMP-1+	NULL
PCNSL	NULL
generally	NULL
express	NULL
BCL-2	NULL
.	NULL

!	NULL

°	NULL
Conversely	NULL
,	NULL
the	NULL
majority	NULL
of	NULL
BCL-6+/LMP-1~	NULL
PCNSL	NULL
are	NULL
BCL-2~	NULL
.	NULL

The	NULL
expression	NULL
pattern	NULL
of	NULL
BCL-6	NULL
,	NULL
LMP-1	NULL
,	NULL
and	NULL
BCL-2	NULL
might	NULL
bear	NULL
practical	NULL
implications	NULL
for	NULL
the	NULL
differential	NULL
diagnosis	NULL
of	NULL
PCNSL	NULL
morphologic	NULL
subtypes	NULL
,	NULL
which	NULL
are	NULL
known	NULL
to	NULL
display	NULL
a	NULL
certain	NULL
degree	NULL
of	NULL
overlap	NULL
when	NULL
classified	NULL
on	NULL
pure	NULL
histologic	NULL
grounds	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
different	NULL
expression	NULL
patterns	NULL
of	NULL
BCL-6	NULL
,	NULL
LMP-1	NULL
,	NULL
and	NULL
BCL-2	NULL
preferentially	NULL
associate	NULL
with	NULL
distinct	NULL
histologic	NULL
variants	NULL
of	NULL
the	NULL
disease	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
BCL-6+/LMP-1~/	NULL
BCL-2~	NULL
PCNSL	NULL
tend	NULL
to	NULL
display	NULL
a	NULL
large	NULL
noncleaved	NULL
cell	NULL
morphology	NULL
,	NULL
whereas	NULL
BCL-6~/LMP-1*/BCL-2+*	NULL
PCNSL	NULL
are	NULL
mainly	NULL
represented	NULL
by	NULL
lymphomas	NULL
with	NULL
immunoblastic	NULL
features	NULL
.	NULL

On	NULL
this	NULL
basis	NULL
,	NULL
it	NULL
is	NULL
conceivable	NULL
that	NULL
expression	NULL
of	NULL
BCL-6	NULL
,	NULL
LMP-1	NULL
,	NULL
and	NULL
BCL-2	NULL
may	NULL
contribute	NULL
a	NULL
valuable	NULL
tool	NULL
for	NULL
the	NULL
differential	NULL
diagnosis	NULL
of	NULL
PCNSL	NULL
histologic	NULL
variants	NULL
.	NULL

Ongoing	NULL
studies	NULL
are	NULL
aimed	NULL
at	NULL
clarifying	NULL
the	NULL
clinical	NULL
relevance	NULL
of	NULL
the	NULL
PCNSL	NULL
phenotypic	NULL
heterogeneity	NULL
in	NULL
terms	NULL
of	NULL
the	NULL
host	NULL
's	NULL
immune	NULL
status	NULL
,	NULL
response	NULL
to	NULL
treatment	NULL
,	NULL
and	NULL
outcome	NULL
.	NULL

ACKNOWLEDGMENT	NULL
The	NULL
MoAb	NULL
,	NULL
PG-B6	NULL
,	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
Prof	NULL
Brunangelo	NULL
Falini	NULL
(	NULL
Institute	NULL
of	NULL
Hematology	NULL
,	NULL
University	NULL
of	NULL
Perugia	NULL
,	NULL
Perugia	NULL
,	NULL
Italy	NULL
)	NULL
.	NULL

The	NULL
human	NULL
BCL-6	NULL
probes	NULL
Sac	NULL
4.0	NULL
and	NULL
Sac	NULL
0.8	NULL
were	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
Dr	NULL
Riccardo	NULL
Dalla-Favera	NULL
(	NULL
Division	NULL
of	NULL
Oncology	NULL
,	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
College	NULL
of	NULL
Physicians	NULL
&	NULL
Surgeons	NULL
,	NULL
Columbia	NULL
University	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Levine	NULL
AM	NULL
:	NULL
AIDS-related	NULL
malignancies	NULL
:	NULL
The	NULL
emerging	NULL
epidemic	NULL
.	NULL

J	NULL
Natl	NULL
Cancer	NULL
Inst	NULL
85:1382	NULL
,	NULL
1993	NULL
2	NULL
.	NULL

DeAngelis	NULL
LM	NULL
,	NULL
Yahalom	NULL
J	NULL
:	NULL
Primary	NULL
central	NULL
nervous	NULL
system	NULL
lymphoma	NULL
,	NULL
in	NULL
DeVita	NULL
VT	NULL
,	NULL
Hellman	NULL
S	NULL
,	NULL
Rosenberg	NULL
SA	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Cancer	NULL
.	NULL

Principles	NULL
and	NULL
Practice	NULL
of	NULL
Oncology	NULL
.	NULL

Philadelphia	NULL
,	NULL
PA	NULL
,	NULL
Lippincott-Raven	NULL
,	NULL
1997	NULL
,	NULL
p	NULL
2233	NULL
3	NULL
.	NULL

Goplen	NULL
AK	NULL
,	NULL
Dunlop	NULL
0	NULL
,	NULL
Hardy	NULL
CR	NULL
,	NULL
Yellin	NULL
FJ	NULL
,	NULL
Hartge	NULL
P	NULL
:	NULL
The	NULL
impact	NULL
of	NULL
primary	NULL
central	NULL
nervous	NULL
system	NULL
lymphoma	NULL
in	NULL
AIDS	NULL
patients	NULL
:	NULL
A	NULL
population-based	NULL
autopsy	NULL
study	NULL
from	NULL
Oslo	NULL
.	NULL

J	NULL
Acquir	NULL
Immune	NULL
Defic	NULL
Syndr	NULL
Human	NULL
Retrovirol	NULL
14:351	NULL
,	NULL
1997	NULL
4	NULL
.	NULL

Fine	NULL
HA	NULL
,	NULL
Loeffler	NULL
JS	NULL
:	NULL
Primary	NULL
central	NULL
nervous	NULL
system	NULL
lymphoma	NULL
,	NULL
in	NULL
Canellos	NULL
GP	NULL
,	NULL
Lister	NULL
TA	NULL
,	NULL
Sklar	NULL
JL	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
The	NULL
Lymphomas	NULL
.	NULL

Philadelphia	NULL
,	NULL
PA	NULL
,	NULL
Saunders	NULL
,	NULL
1998	NULL
,	NULL
p	NULL
481	NULL
5	NULL
.	NULL

Beral	NULL
V	NULL
,	NULL
Peterman	NULL
T	NULL
,	NULL
Berkelman	NULL
R	NULL
,	NULL
Jaffe	NULL
H	NULL
:	NULL
AIDS-associated	NULL
non-Hodgkin	NULL
lymphoma	NULL
.	NULL

Lancet	NULL
337:805	NULL
,	NULL
1991	NULL
6	NULL
.	NULL

Coté	NULL
TR	NULL
,	NULL
Manns	NULL
A	NULL
,	NULL
Hardy	NULL
CR	NULL
,	NULL
Yellin	NULL
FJ	NULL
,	NULL
Hartge	NULL
P	NULL
:	NULL
Epidemiology	NULL
of	NULL
brain	NULL
lymphoma	NULL
among	NULL
people	NULL
with	NULL
or	NULL
without	NULL
acquired	NULL
immunodeficiency	NULL
syndrome	NULL
.	NULL

J	NULL
Natl	NULL
Cancer	NULL
Inst	NULL
88:675	NULL
,	NULL
1996	NULL
7	NULL
.	NULL

Miller	NULL
DC	NULL
,	NULL
Hochberg	NULL
FH	NULL
,	NULL
Harris	NULL
NL	NULL
:	NULL
CNS	NULL
lymphoma	NULL
update	NULL
.	NULL

J	NULL
Neurooncol	NULL
12:264	NULL
,	NULL
1992	NULL
8	NULL
.	NULL

Jellinger	NULL
KA	NULL
,	NULL
Paulus	NULL
W	NULL
:	NULL
Primary	NULL
central	NULL
nervous	NULL
system	NULL
lymphomas	NULL
:	NULL
An	NULL
update	NULL
.	NULL

J	NULL
Cancer	NULL
Res	NULL
Clin	NULL
Oncol	NULL
119:7	NULL
,	NULL
1992	NULL
9	NULL
.	NULL

Camilleri-Broet	NULL
S	NULL
,	NULL
Davi	NULL
F	NULL
,	NULL
Feuillard	NULL
J	NULL
,	NULL
Seilhean	NULL
D	NULL
,	NULL
Michiels	NULL
JF	NULL
,	NULL
Brousset	NULL
P	NULL
,	NULL
Epardeau	NULL
B	NULL
,	NULL
Navratil	NULL
E	NULL
,	NULL
Mokhtari	NULL
K	NULL
,	NULL
Bourgeois	NULL
C	NULL
,	NULL
Marelle	NULL
L	NULL
,	NULL
Raphael	NULL
M	NULL
,	NULL
Hauw	NULL
J-J	NULL
and	NULL
the	NULL
French	NULL
Study	NULL
Group	NULL
for	NULL
HIV-Associated	NULL
Tumors	NULL
:	NULL
AIDS-related	NULL
primary	NULL
brain	NULL
lymphomas	NULL
:	NULL
Histopatho-logic	NULL
and	NULL
immunohistochemical	NULL
study	NULL
of	NULL
51	NULL
cases	NULL
.	NULL

Hum	NULL
Pathol	NULL
28:367	NULL
,	NULL
1997	NULL
10	NULL
.	NULL

MacMahon	NULL
EME	NULL
,	NULL
Glass	NULL
JD	NULL
,	NULL
Hayward	NULL
SD	NULL
,	NULL
Mann	NULL
RB	NULL
,	NULL
Beker	NULL
PS	NULL
,	NULL
LAROCCA	NULL
ET	NULL
AL	NULL
Charache	NULL
P	NULL
,	NULL
McArthur	NULL
JC	NULL
,	NULL
Ambinder	NULL
RF	NULL
:	NULL
Epstein-Barr	NULL
virus	NULL
in	NULL
AIDS-related	NULL
primary	NULL
central	NULL
nervous	NULL
system	NULL
lymphoma	NULL
.	NULL

Lancet	NULL
338:969	NULL
,	NULL
1991	NULL
11	NULL
.	NULL

Geddes	NULL
JF	NULL
,	NULL
Bhattacharjee	NULL
MB	NULL
,	NULL
Savage	NULL
K	NULL
,	NULL
Scaravilli	NULL
F	NULL
,	NULL
McLaughlin	NULL
JE	NULL
:	NULL
Primary	NULL
cerebral	NULL
lymphoma	NULL
:	NULL
A	NULL
study	NULL
of	NULL
47	NULL
cases	NULL
probed	NULL
for	NULL
Epstein-Barr	NULL
virus	NULL
genome	NULL
.	NULL

J	NULL
Clin	NULL
Pathol	NULL
45:587	NULL
,	NULL
1992	NULL
12	NULL
.	NULL

Morgello	NULL
S	NULL
:	NULL
Epstein-Barr	NULL
and	NULL
human	NULL
immunodeficiency	NULL
viruses	NULL
in	NULL
acquired	NULL
immunodeficiency	NULL
syndrome-related	NULL
primary	NULL
central	NULL
nervous	NULL
system	NULL
lymphoma	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
141:441	NULL
,	NULL
1992	NULL
13	NULL
.	NULL

Hamilton-Dutoit	NULL
SJ	NULL
,	NULL
Rea	NULL
D	NULL
,	NULL
Raphael	NULL
M	NULL
,	NULL
Sandvej	NULL
K	NULL
,	NULL
Delecluse	NULL
HJ	NULL
,	NULL
Gisselbrecht	NULL
C	NULL
,	NULL
Marelle	NULL
L	NULL
,	NULL
van	NULL
Kricken	NULL
JHJM	NULL
,	NULL
Pallesen	NULL
G	NULL
:	NULL
Epstein-Barr	NULL
virus-latent	NULL
gene	NULL
expression	NULL
and	NULL
tumor	NULL
cell	NULL
phenotype	NULL
in	NULL
acquired	NULL
immunodeficiency	NULL
syndrome-related	NULL
non-Hodgkin	NULL
's	NULL
lymphoma	NULL
.	NULL

Correlation	NULL
of	NULL
lymphoma	NULL
phenotype	NULL
with	NULL
three	NULL
distinct	NULL
patterns	NULL
of	NULL
viral	NULL
latency	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
143:1072	NULL
,	NULL
1993	NULL
14	NULL
.	NULL

Itoyama	NULL
T	NULL
,	NULL
Sadamori	NULL
N	NULL
,	NULL
Tsutsumi	NULL
K	NULL
,	NULL
Tokunaga	NULL
Y	NULL
,	NULL
Soda	NULL
H	NULL
,	NULL
Tomonaga	NULL
M	NULL
,	NULL
Yamamori	NULL
S	NULL
,	NULL
Masuda	NULL
Y	NULL
,	NULL
Oshima	NULL
K	NULL
,	NULL
Kikuchi	NULL
M	NULL
:	NULL
Primary	NULL
central	NULL
nervous	NULL
system	NULL
lymphomas	NULL
.	NULL

Immunophenotypic	NULL
,	NULL
virologic	NULL
,	NULL
and	NULL
cytogenetic	NULL
findings	NULL
of	NULL
three	NULL
patients	NULL
without	NULL
immune	NULL
defects	NULL
.	NULL

Cancer	NULL
73:455	NULL
,	NULL
1995	NULL
15	NULL
.	NULL

Antinori	NULL
A	NULL
,	NULL
Ammassari	NULL
A	NULL
,	NULL
De	NULL
Luca	NULL
A	NULL
,	NULL
Cingolani	NULL
A	NULL
,	NULL
Murri	NULL
R	NULL
,	NULL
Scoppettuolo	NULL
G	NULL
,	NULL
Fortin	NULL
M	NULL
,	NULL
Tartaglione	NULL
T	NULL
,	NULL
Larocca	NULL
LM	NULL
,	NULL
Zannoni	NULL
G	NULL
,	NULL
Cattani	NULL
P	NULL
,	NULL
Grillo	NULL
R	NULL
,	NULL
Roselli	NULL
R	NULL
,	NULL
Iacoangeli	NULL
M	NULL
,	NULL
Scerrati	NULL
M	NULL
,	NULL
Ortona	NULL
L	NULL
:	NULL
Diagnosis	NULL
of	NULL
AIDS-related	NULL
focal	NULL
brain	NULL
lesions	NULL
:	NULL
A	NULL
decision-making	NULL
analysis	NULL
based	NULL
on	NULL
clinical	NULL
and	NULL
neuroradiologic	NULL
characteristics	NULL
combined	NULL
with	NULL
polymerase	NULL
chain	NULL
reaction	NULL
assays	NULL
in	NULL
CSF	NULL
.	NULL

Neurology	NULL
48:687	NULL
,	NULL
1997	NULL
16	NULL
.	NULL

Camilleri-Broet	NULL
S	NULL
,	NULL
Davi	NULL
F	NULL
,	NULL
Feuillard	NULL
J	NULL
,	NULL
Bourgeois	NULL
C	NULL
,	NULL
Seilhean	NULL
D	NULL
,	NULL
Hauw	NULL
J-J	NULL
,	NULL
Raphael	NULL
M	NULL
:	NULL
High	NULL
expression	NULL
of	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
and	NULL
BCL-2	NULL
oncoprotein	NULL
in	NULL
acquired	NULL
immunodeficiency	NULL
syndrome-related	NULL
primary	NULL
brain	NULL
lymphomas	NULL
.	NULL

Blood	NULL
86:432	NULL
,	NULL
1995	NULL
17	NULL
.	NULL

Ye	NULL
BH	NULL
,	NULL
Rao	NULL
PH	NULL
,	NULL
Chaganti	NULL
RSK	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Cloning	NULL
of	NULL
BCL-6	NULL
,	NULL
the	NULL
locus	NULL
involved	NULL
in	NULL
chromosome	NULL
translocations	NULL
affecting	NULL
band	NULL
3q27	NULL
in	NULL
B-cell	NULL
lymphoma	NULL
.	NULL

Cancer	NULL
Res	NULL
53:2732	NULL
,	NULL
1993	NULL
18	NULL
.	NULL

Ye	NULL
BH	NULL
,	NULL
Lista	NULL
F	NULL
,	NULL
Lo	NULL
Coco	NULL
F	NULL
,	NULL
Knowles	NULL
DM	NULL
,	NULL
Chaganti	NULL
RSK	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Alterations	NULL
of	NULL
BCL-6	NULL
,	NULL
a	NULL
novel	NULL
zinc-finger	NULL
gene	NULL
,	NULL
in	NULL
diffuse	NULL
large	NULL
cell	NULL
lymphoma	NULL
.	NULL

Science	NULL
262:747	NULL
,	NULL
1993	NULL
19	NULL
.	NULL

Baron	NULL
BW	NULL
,	NULL
Nucifora	NULL
G	NULL
,	NULL
McNabe	NULL
N	NULL
,	NULL
Espinosa	NULL
R	NULL
III	NULL
,	NULL
Le	NULL
Beau	NULL
MM	NULL
,	NULL
McKeithan	NULL
TW	NULL
:	NULL
Identification	NULL
of	NULL
the	NULL
gene	NULL
associated	NULL
with	NULL
the	NULL
recurrent	NULL
chromosomal	NULL
translocations	NULL
t	NULL
(	NULL
3	NULL
;	NULL
14	NULL
)	NULL
(	NULL
q27	NULL
;	NULL
q32	NULL
)	NULL
and	NULL
t	NULL
(	NULL
3	NULL
;	NULL
22	NULL
)	NULL
(	NULL
q27	NULL
;	NULL
q11	NULL
)	NULL
in	NULL
B-cell	NULL
lymphomas	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:5262	NULL
,	NULL
1993	NULL
20	NULL
.	NULL

Kerckaert	NULL
J-P	NULL
,	NULL
Deweindt	NULL
C	NULL
,	NULL
Tilly	NULL
H	NULL
,	NULL
Quief	NULL
S	NULL
,	NULL
Lecocq	NULL
G	NULL
,	NULL
Bastard	NULL
C	NULL
:	NULL
LAZ3	NULL
,	NULL
a	NULL
novel	NULL
zinc-finger	NULL
encoding	NULL
gene	NULL
,	NULL
is	NULL
disrupted	NULL
by	NULL
recurring	NULL
chromosome	NULL
3q27	NULL
translocations	NULL
in	NULL
human	NULL
lymphoma	NULL
.	NULL

Nat	NULL
Genet	NULL
5:66	NULL
,	NULL
1993	NULL
21	NULL
.	NULL

Cattoretti	NULL
G	NULL
,	NULL
Chang	NULL
CC	NULL
,	NULL
Cechova	NULL
K	NULL
,	NULL
Zhang	NULL
J	NULL
,	NULL
Ye	NULL
BH	NULL
,	NULL
Falini	NULL
B	NULL
,	NULL
Louie	NULL
DC	NULL
,	NULL
Offit	NULL
K	NULL
,	NULL
Chaganti	NULL
RS	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
BCL-6	NULL
protein	NULL
is	NULL
expressed	NULL
in	NULL
germinal-center	NULL
B	NULL
cells	NULL
.	NULL

Blood	NULL
86:45	NULL
,	NULL
1995	NULL
22	NULL
.	NULL

Dent	NULL
AL	NULL
,	NULL
Shaffer	NULL
AL	NULL
,	NULL
Yu	NULL
X	NULL
,	NULL
Allman	NULL
D	NULL
,	NULL
Staudt	NULL
LM	NULL
:	NULL
Control	NULL
of	NULL
inflammation	NULL
,	NULL
cytokine	NULL
expression	NULL
,	NULL
and	NULL
germinal	NULL
center	NULL
formation	NULL
by	NULL
BCL-6	NULL
.	NULL

Science	NULL
276:589	NULL
,	NULL
1997	NULL
23	NULL
.	NULL

Ye	NULL
BH	NULL
,	NULL
Cattoretti	NULL
G	NULL
,	NULL
Shen	NULL
Q	NULL
,	NULL
Zhang	NULL
J	NULL
,	NULL
Hawe	NULL
N	NULL
,	NULL
de	NULL
Waard	NULL
R	NULL
,	NULL
Leung	NULL
C	NULL
,	NULL
Nouri-Shirazi	NULL
M	NULL
,	NULL
Orazi	NULL
A	NULL
,	NULL
Chaganti	NULL
RS	NULL
,	NULL
Rothman	NULL
P	NULL
,	NULL
Stall	NULL
AM	NULL
,	NULL
Pandolfi	NULL
PP	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
The	NULL
BCL-6	NULL
proto-oncogene	NULL
controls	NULL
germinal-centre	NULL
formation	NULL
and	NULL
Th2-type	NULL
inflammation	NULL
.	NULL

Nat	NULL
Genet	NULL
16:161	NULL
,	NULL
1997	NULL
24	NULL
.	NULL

Migliazza	NULL
A	NULL
,	NULL
Martinotti	NULL
S	NULL
,	NULL
Chen	NULL
W	NULL
,	NULL
Fusco	NULL
C	NULL
,	NULL
Ye	NULL
BY	NULL
,	NULL
Knowles	NULL
DM	NULL
,	NULL
Offit	NULL
K	NULL
,	NULL
Chaganti	NULL
RSK	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Frequent	NULL
somatic	NULL
hypermutation	NULL
of	NULL
the	NULL
5	NULL
noncoding	NULL
region	NULL
of	NULL
the	NULL
BCL6	NULL
gene	NULL
in	NULL
B-cell	NULL
lymphoma	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
92:12520	NULL
,	NULL
1995	NULL
25	NULL
.	NULL

Lo	NULL
Coco	NULL
F	NULL
,	NULL
Ye	NULL
BH	NULL
,	NULL
Lista	NULL
F	NULL
,	NULL
Corradini	NULL
P	NULL
,	NULL
Offit	NULL
K	NULL
,	NULL
Knowles	NULL
DM	NULL
,	NULL
Chaganti	NULL
RSK	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Rearrangements	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
in	NULL
diffuse	NULL
large	NULL
cell	NULL
non-Hodgkin	NULL
lymphoma	NULL
.	NULL

Blood	NULL
83:1757	NULL
,	NULL
1994	NULL
26	NULL
.	NULL

Gaidano	NULL
G	NULL
,	NULL
Carbone	NULL
A	NULL
,	NULL
Pastore	NULL
C	NULL
,	NULL
Capello	NULL
D	NULL
,	NULL
Migliazza	NULL
A	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Roncella	NULL
S	NULL
,	NULL
Ferrarini	NULL
M	NULL
,	NULL
Saglio	NULL
G	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

HISTOGENETIC	NULL
AND	NULL
PATHOGENETIC	NULL
FEATURES	NULL
OF	NULL
PCNSL	NULL
Frequent	NULL
mutation	NULL
of	NULL
the	NULL
5	NULL
noncoding	NULL
region	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
in	NULL
acquired	NULL
immunodeficiency	NULL
syndrome-related	NULL
non-Hodgkin	NULL
's	NULL
lymphomas	NULL
.	NULL

Blood	NULL
89:3755	NULL
,	NULL
1997	NULL
27	NULL
.	NULL

Gaidano	NULL
G	NULL
,	NULL
Pastore	NULL
C	NULL
,	NULL
Capello	NULL
D	NULL
,	NULL
Migliazza	NULL
A	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Saglio	NULL
G	NULL
,	NULL
Carbone	NULL
A	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Involvement	NULL
of	NULL
the	NULL
be/-6	NULL
gene	NULL
in	NULL
AIDS-related	NULL
lymphomas	NULL
.	NULL

Ann	NULL
Oncol	NULL
8	NULL
:	NULL
$	NULL
105	NULL
,	NULL
1997	NULL
(	NULL
suppl	NULL
2	NULL
)	NULL
28	NULL
.	NULL

Capello	NULL
D	NULL
,	NULL
Carbone	NULL
A	NULL
,	NULL
Pastore	NULL
C	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Saglio	NULL
G	NULL
,	NULL
Gaidano	NULL
G	NULL
:	NULL
Point	NULL
mutations	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
99:168	NULL
,	NULL
1997	NULL
29	NULL
.	NULL

Non-Hodgkin	NULL
's	NULL
Lymphoma	NULL
Pathologic	NULL
Classification	NULL
Project	NULL
.	NULL

National	NULL
Cancer	NULL
Institute	NULL
sponsored	NULL
study	NULL
of	NULL
classification	NULL
of	NULL
non-Hodgkin	NULL
's	NULL
lymphomas	NULL
:	NULL
Summary	NULL
and	NULL
description	NULL
of	NULL
a	NULL
Working	NULL
Formulation	NULL
for	NULL
clinical	NULL
usage	NULL
.	NULL

Cancer	NULL
49:2112	NULL
,	NULL
1982	NULL
30	NULL
.	NULL

Harris	NULL
NL	NULL
,	NULL
Jaffe	NULL
ES	NULL
,	NULL
Stein	NULL
H	NULL
,	NULL
Banks	NULL
PM	NULL
,	NULL
Chan	NULL
JKC	NULL
,	NULL
Cleary	NULL
ML	NULL
,	NULL
Delsol	NULL
G	NULL
,	NULL
De	NULL
Wolfe-Peters	NULL
C	NULL
,	NULL
Falini	NULL
B	NULL
,	NULL
Gaiter	NULL
KC	NULL
,	NULL
Grogan	NULL
TM	NULL
,	NULL
Isaacson	NULL
PG	NULL
,	NULL
Knowles	NULL
DM	NULL
,	NULL
Mason	NULL
DY	NULL
,	NULL
Muller-Hermelink	NULL
H-K	NULL
,	NULL
Pileri	NULL
S	NULL
,	NULL
Piris	NULL
MA	NULL
,	NULL
Ralfkiaer	NULL
E	NULL
,	NULL
Warnke	NULL
RA	NULL
:	NULL
A	NULL
revised	NULL
European-American	NULL
classification	NULL
of	NULL
lymphoid	NULL
neoplasms	NULL
:	NULL
A	NULL
proposal	NULL
from	NULL
the	NULL
International	NULL
Lymphoma	NULL
Study	NULL
Group	NULL
.	NULL

Blood	NULL
84:1361	NULL
,	NULL
1994	NULL
31	NULL
.	NULL

Carbone	NULL
A	NULL
,	NULL
Gaidano	NULL
G	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Pastore	NULL
C	NULL
,	NULL
Saglio	NULL
G	NULL
,	NULL
Tirelli	NULL
U	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
,	NULL
Falini	NULL
B	NULL
:	NULL
BCL-6	NULL
protein	NULL
expression	NULL
in	NULL
AIDS-related	NULL
non-Hodgkin	NULL
's	NULL
lymphomas	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
150:155	NULL
,	NULL
1997	NULL
32	NULL
.	NULL

Carbone	NULL
A	NULL
,	NULL
Gaidano	NULL
G	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Larocca	NULL
LM	NULL
,	NULL
Capello	NULL
D	NULL
,	NULL
Canzonieri	NULL
V	NULL
,	NULL
Antinori	NULL
A	NULL
,	NULL
Tirelli	NULL
U	NULL
,	NULL
Falini	NULL
B	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Differential	NULL
expression	NULL
of	NULL
BCL-6	NULL
,	NULL
CD138/syndecan-1	NULL
,	NULL
and	NULL
Epstein-Barr	NULL
virus-encoded	NULL
latent	NULL
membrane	NULL
protein-1	NULL
identifies	NULL
distinct	NULL
histogenetic	NULL
subsets	NULL
of	NULL
acquired	NULL
immunodeficiency	NULL
syndrome-related	NULL
non-Hodgkin	NULL
's	NULL
lymphomas	NULL
.	NULL

Blood	NULL
91:747	NULL
,	NULL
1998	NULL
33	NULL
.	NULL

Flenghi	NULL
L	NULL
,	NULL
Ye	NULL
BH	NULL
,	NULL
Fizzotti	NULL
M	NULL
,	NULL
Bigema	NULL
B	NULL
,	NULL
Cattoretti	NULL
G	NULL
,	NULL
Venturi	NULL
S	NULL
,	NULL
Pacini	NULL
R	NULL
,	NULL
Pileri	NULL
S	NULL
,	NULL
Lo	NULL
Coco	NULL
F	NULL
,	NULL
Pescarmona	NULL
E	NULL
,	NULL
Pelicci	NULL
P-G	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
,	NULL
Falini	NULL
B	NULL
:	NULL
A	NULL
specific	NULL
monoclonal	NULL
antibody	NULL
(	NULL
PG-B6	NULL
)	NULL
detects	NULL
expression	NULL
of	NULL
the	NULL
BCL-6	NULL
protein	NULL
in	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
147:405	NULL
,	NULL
1995	NULL
34	NULL
.	NULL

Carbone	NULL
A	NULL
,	NULL
Tirelli	NULL
U	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Volpe	NULL
R	NULL
,	NULL
Boiocchi	NULL
M	NULL
:	NULL
Human	NULL
immunodeficiency	NULL
virus-associated	NULL
systemic	NULL
lymphomas	NULL
may	NULL
be	NULL
subdivided	NULL
into	NULL
two	NULL
main	NULL
groups	NULL
according	NULL
to	NULL
Epstein-Barr	NULL
viral	NULL
latent	NULL
gene	NULL
expression	NULL
.	NULL

J	NULL
Clin	NULL
Oncol	NULL
11:1674	NULL
,	NULL
1993	NULL
35	NULL
.	NULL

Miller	NULL
SA	NULL
,	NULL
Dykes	NULL
DD	NULL
,	NULL
Polesky	NULL
HF	NULL
:	NULL
A	NULL
simple	NULL
salting	NULL
out	NULL
procedure	NULL
for	NULL
extracting	NULL
DNA	NULL
from	NULL
human	NULL
nucleated	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
16:1215	NULL
,	NULL
1988	NULL
36	NULL
.	NULL

Gaidano	NULL
G	NULL
,	NULL
Pastore	NULL
C	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Cusini	NULL
M	NULL
,	NULL
Nomdedeu	NULL
J	NULL
,	NULL
Volpe	NULL
G	NULL
,	NULL
Capello	NULL
D	NULL
,	NULL
Vaccher	NULL
E	NULL
,	NULL
Bordes	NULL
R	NULL
,	NULL
Tirelli	NULL
U	NULL
,	NULL
Saglio	NULL
G	NULL
,	NULL
Carbone	NULL
A	NULL
:	NULL
Distribution	NULL
of	NULL
human	NULL
herpesvirus-8	NULL
sequences	NULL
throughout	NULL
the	NULL
spectrum	NULL
of	NULL
AIDS-related	NULL
neoplasia	NULL
.	NULL

AIDS	NULL
10:941	NULL
,	NULL
1996	NULL
1019	NULL
37	NULL
.	NULL

Ballerini	NULL
P	NULL
,	NULL
Gaidano	NULL
G	NULL
,	NULL
Gong	NULL
JZ	NULL
,	NULL
Tassi	NULL
V	NULL
,	NULL
Saglio	NULL
G	NULL
,	NULL
Knowles	NULL
DM	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Multiple	NULL
genetic	NULL
lesions	NULL
in	NULL
acquired	NULL
immunodeficiency	NULL
syndrome-related	NULL
non-Hodgkin	NULL
's	NULL
lymphoma	NULL
.	NULL

Blood	NULL
81:166	NULL
,	NULL
1993	NULL
38	NULL
.	NULL

Volpe	NULL
G	NULL
,	NULL
Vitolo	NULL
U	NULL
,	NULL
Carbone	NULL
A	NULL
,	NULL
Pastore	NULL
C	NULL
,	NULL
Bertini	NULL
M	NULL
,	NULL
Botto	NULL
B	NULL
,	NULL
Audisio	NULL
E	NULL
,	NULL
Freilone	NULL
R	NULL
,	NULL
Novero	NULL
D	NULL
,	NULL
Cappia	NULL
S	NULL
,	NULL
De	NULL
Giuli	NULL
P	NULL
,	NULL
Mazza	NULL
U	NULL
,	NULL
Resegotti	NULL
L	NULL
,	NULL
Palestro	NULL
G	NULL
,	NULL
Saglio	NULL
G	NULL
,	NULL
Gaidano	NULL
G	NULL
:	NULL
Molecular	NULL
heterogeneity	NULL
of	NULL
B-lineage	NULL
diffuse	NULL
large	NULL
cell	NULL
lymphoma	NULL
.	NULL

Genes	NULL
Chromosom	NULL
Cancer	NULL
16:21	NULL
,	NULL
1996	NULL
39	NULL
.	NULL

Lennert	NULL
K	NULL
,	NULL
Feller	NULL
A	NULL
:	NULL
Histopathology	NULL
of	NULL
non-Hodgkin	NULL
's	NULL
Lymphomas	NULL
(	NULL
ed	NULL
2	NULL
)	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Springer-Verlag	NULL
,	NULL
1992	NULL
40	NULL
.	NULL

Fishel	NULL
R	NULL
,	NULL
Lescoe	NULL
MK	NULL
,	NULL
Rao	NULL
MR	NULL
,	NULL
Copeland	NULL
NG	NULL
,	NULL
Jenkins	NULL
NA	NULL
,	NULL
Garber	NULL
J	NULL
,	NULL
Kane	NULL
M	NULL
,	NULL
Kolodner	NULL
R	NULL
:	NULL
The	NULL
human	NULL
mutator	NULL
gene	NULL
homolog	NULL
MSH2	NULL
and	NULL
its	NULL
association	NULL
with	NULL
hereditary	NULL
nonpolyposis	NULL
colon	NULL
cancer	NULL
.	NULL

Cell	NULL
75:1027	NULL
,	NULL
1993	NULL
41	NULL
.	NULL

Wilson	NULL
TM	NULL
,	NULL
Ewel	NULL
A	NULL
,	NULL
Duguid	NULL
JR	NULL
,	NULL
Eble	NULL
JN	NULL
,	NULL
Lescoe	NULL
MK	NULL
,	NULL
Fishel	NULL
R	NULL
,	NULL
Kelley	NULL
MR	NULL
:	NULL
Differential	NULL
cellular	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
MSH2	NULL
repair	NULL
enzyme	NULL
in	NULL
small	NULL
and	NULL
large	NULL
intestine	NULL
.	NULL

Cancer	NULL
Res	NULL
55:5146	NULL
,	NULL
1995	NULL
42	NULL
.	NULL

Leach	NULL
FS	NULL
,	NULL
Polyak	NULL
K	NULL
,	NULL
Burrell	NULL
M	NULL
,	NULL
Johnson	NULL
KA	NULL
,	NULL
Hill	NULL
D	NULL
,	NULL
Dunlop	NULL
MG	NULL
,	NULL
Wyllie	NULL
AH	NULL
,	NULL
Paltomaki	NULL
P	NULL
,	NULL
de	NULL
la	NULL
Chapelle	NULL
A	NULL
,	NULL
Hamilton	NULL
SR	NULL
,	NULL
Kinzler	NULL
KW	NULL
,	NULL
Vogelstein	NULL
B	NULL
:	NULL
Expression	NULL
of	NULL
the	NULL
human	NULL
mismatch	NULL
repair	NULL
gene	NULL
hMSH2	NULL
in	NULL
normal	NULL
and	NULL
neoplastic	NULL
tissues	NULL
.	NULL

Cancer	NULL
Res	NULL
56:235	NULL
,	NULL
1996	NULL
43	NULL
.	NULL

Marra	NULL
G	NULL
,	NULL
Chang	NULL
CL	NULL
,	NULL
Laghi	NULL
LA	NULL
,	NULL
Chauban	NULL
DP	NULL
,	NULL
Young	NULL
D	NULL
,	NULL
Boland	NULL
R	NULL
:	NULL
Expression	NULL
of	NULL
human	NULL
MutS	NULL
homolog	NULL
2	NULL
protein	NULL
in	NULL
resting	NULL
and	NULL
proliferating	NULL
cells	NULL
.	NULL

Oncogene	NULL
13:2189	NULL
,	NULL
1996	NULL
44	NULL
.	NULL

Thibodeau	NULL
SN	NULL
,	NULL
French	NULL
AJ	NULL
,	NULL
Roche	NULL
PC	NULL
,	NULL
Cunningham	NULL
JM	NULL
,	NULL
Tester	NULL
DJ	NULL
,	NULL
Lindor	NULL
NM	NULL
,	NULL
Moslein	NULL
G	NULL
,	NULL
Baker	NULL
SM	NULL
,	NULL
Liskay	NULL
RM	NULL
,	NULL
Burgart	NULL
LJ	NULL
,	NULL
Honchel	NULL
R	NULL
,	NULL
Halling	NULL
KC	NULL
:	NULL
Altered	NULL
expression	NULL
of	NULL
hMSH2	NULL
and	NULL
hMLH1	NULL
in	NULL
tumors	NULL
with	NULL
microsatellite	NULL
instability	NULL
and	NULL
genetic	NULL
alterations	NULL
in	NULL
mismatch	NULL
repair	NULL
genes	NULL
.	NULL

Cancer	NULL
Res	NULL
56:4836	NULL
,	NULL
1996	NULL
45	NULL
.	NULL

Migliazza	NULL
A	NULL
,	NULL
Ye	NULL
BH	NULL
,	NULL
Fracchiolla	NULL
N	NULL
,	NULL
Neri	NULL
A	NULL
,	NULL
Baldini	NULL
L	NULL
,	NULL
Chaganti	NULL
RSK	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Mutation	NULL
of	NULL
the	NULL
5	NULL
'	NULL
non-coding	NULL
region	NULL
of	NULL
BCL-6	NULL
are	NULL
common	NULL
in	NULL
B	NULL
cell	NULL
malignancies	NULL
and	NULL
can	NULL
deregulate	NULL
BCL-6	NULL
expression	NULL
.	NULL

Blood	NULL
90:177a	NULL
,	NULL
1997	NULL
(	NULL
suppl	NULL
1	NULL
)	NULL
46	NULL
.	NULL

Gaidano	NULL
G	NULL
,	NULL
Lo	NULL
Coco	NULL
F	NULL
,	NULL
Ye	NULL
BH	NULL
,	NULL
Shibata	NULL
D	NULL
,	NULL
Levine	NULL
AM	NULL
,	NULL
Knowles	NULL
DM	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Rearrangements	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
in	NULL
acquired	NULL
immunodeficiency	NULL
syndrome-associated	NULL
non-Hodgkin	NULL
's	NULL
lymphoma	NULL
:	NULL
Association	NULL
with	NULL
diffuse	NULL
large-cell	NULL
subtype	NULL
.	NULL

Blood	NULL
84:397	NULL
,	NULL
1994	NULL
47	NULL
.	NULL

Cattoretti	NULL
G	NULL
,	NULL
Zhang	NULL
J	NULL
,	NULL
Cleary	NULL
AM	NULL
,	NULL
Lederman	NULL
S	NULL
,	NULL
Gaidano	NULL
G	NULL
,	NULL
Carbone	NULL
A	NULL
,	NULL
Chaganti	NULL
RSK	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Downregulation	NULL
of	NULL
BCL-6	NULL
gene	NULL
expression	NULL
by	NULL
CD40	NULL
and	NULL
EBV	NULL
latent	NULL
membrane	NULL
protein-1	NULL
(	NULL
LMP-1	NULL
)	NULL
and	NULL
its	NULL
block	NULL
in	NULL
lymphoma	NULL
carrying	NULL
BCL-6	NULL
rearrangements	NULL
.	NULL

Blood	NULL
90:175a	NULL
,	NULL
1997	NULL
(	NULL
abstr	NULL
,	NULL
suppl	NULL
1	NULL
)	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blOOd	NULL
1998	NULL
92	NULL
:	NULL
1011-1019	NULL
The	NULL
Molecular	NULL
and	NULL
Phenotypic	NULL
Profile	NULL
of	NULL
Primary	NULL
Central	NULL
Nervous	NULL
System	NULL
Lymphoma	NULL
Identifies	NULL
Distinct	NULL
Categories	NULL
of	NULL
the	NULL
Disease	NULL
and	NULL
Is	NULL
Consistent	NULL
With	NULL
Histogenetic	NULL
Derivation	NULL
From	NULL
Germinal	NULL
Center-Related	NULL
B	NULL
Cells	NULL
A	NULL
_	NULL
g	NULL
``	NULL
JO	NULL
430°	NULL
“	NULL
?	NULL
)	NULL

``	NULL
O19nN	NULL
i	NULL
{	NULL
®	NULL
Luigi	NULL
Maria	NULL
Larocca	NULL
,	NULL
Daniela	NULL
Capello	NULL
,	NULL
Alessandro	NULL
Rinelli	NULL
,	NULL
Simonetta	NULL
Nori	NULL
,	NULL
Andrea	NULL
Antinori	NULL
,	NULL
Annunziata	NULL
Gloghini	NULL
,	NULL
Antonella	NULL
Cingolani	NULL
,	NULL
Anna	NULL
Migliazza	NULL
,	NULL
Giuseppe	NULL
Saglio	NULL
,	NULL
Sophie	NULL
Cammilleri-Broet	NULL
,	NULL
Martine	NULL
Raphael	NULL
,	NULL
Antonino	NULL
Carbone	NULL
and	NULL
Gianluca	NULL
Gaidano	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/92/3/1011.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Neoplasia	NULL
(	NULL
4182	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

